WO2012034498A1 - Product of functional health food that enhances organ immunity - Google Patents

Product of functional health food that enhances organ immunity Download PDF

Info

Publication number
WO2012034498A1
WO2012034498A1 PCT/CN2011/079493 CN2011079493W WO2012034498A1 WO 2012034498 A1 WO2012034498 A1 WO 2012034498A1 CN 2011079493 W CN2011079493 W CN 2011079493W WO 2012034498 A1 WO2012034498 A1 WO 2012034498A1
Authority
WO
WIPO (PCT)
Prior art keywords
parts
extract
product
blood
diabetes
Prior art date
Application number
PCT/CN2011/079493
Other languages
French (fr)
Chinese (zh)
Inventor
武斌
Original Assignee
Wu Bin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wu Bin filed Critical Wu Bin
Publication of WO2012034498A1 publication Critical patent/WO2012034498A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Definitions

  • the invention relates to the field of functional health foods, in particular to a product which enhances immunity of the body and can control diabetes.
  • BACKGROUND OF THE INVENTION Diabetes is a common chronic disease. With the improvement of people's living standards, the aging of the population and the increase in the incidence of obesity, the incidence of diabetes is increasing year by year. According to the report of Jia Chunbao Diabetes Research Institute: At present, the incidence of diabetes in China has reached more than 3%, and the number of diagnosed diabetes patients has reached 45 million, and the rate has increased by about 1.5 million per year. Diabetes is a lifelong disease whose severity is due to a high incidence of complications. People began to pay less attention to diabetes, and complications occurred, and the consequences were quite serious.
  • Podiatry, kidney disease, eye disease, encephalopathy, heart disease, skin disease, and sexually transmitted diseases are the most common complications of diabetes.
  • Studies in the United States have shown that 95% of patients with diabetes for more than 20 years have retinopathy, and those with diabetes die from cardiovascular disease.
  • people with diabetes may also have kidney disease, neuropathy, digestive tract disease, oral disease, impotence, skin and joint diseases, and lower extremity arteriosclerosis obliterans. Because diabetes can affect all systems of the body, it can cause great mental and physical pain to diabetic patients. The best way to avoid and control diabetes complications is to control blood sugar levels.
  • oral hypoglycemic drugs commonly used in clinical practice have side effects, which can cause adverse reactions in the digestive system, and some cause measles, anemia, leukopenia and thrombocytopenia, dizziness and fatigue. Therefore, the search for the development of health foods that enhance the immunity of the body to assist in drug treatment has been attracting attention while effectively controlling blood sugar and diabetic complications while reducing side effects.
  • Diabetes people are hoping to get rid of this dilemma as soon as possible. At present, reasonable diet and nutrition are still important means to prevent and control diabetes and its complications. Although diabetes may cause various complications, experts pointed out that as long as timely intervention, it can completely prevent and delay the effects of complications, especially to change the lifestyle of modern people who "go out and hit the door to find the elevator". Experts stressed that regardless of diabetes, or cardiovascular complications, genetic inheritance only accounts for 10%, 90% is caused by unhealthy lifestyles such as smoking, exercise, irrational diet, and nervousness. The presence or absence of diabetes complications or its severity plays a decisive role in the life and prognosis of diabetic patients. Therefore, for each diabetic patient to have longevity, effective measures should be taken to prevent the occurrence of comorbidities. Chinese traditional Chinese medicine technology has a long history. The common people also pay great attention to food culture. At the same time of drug treatment, food supplementing and strengthening curative effect are common methods used by the people. However, there is no such healthy food for lowering blood sugar curative effect.
  • the present invention provides a product for enhancing immunity and controlling diabetes, and the raw material completely conforms to the homologous standard of medicine and food, and is capable of enhancing immunity of the body and assisting in controlling diabetes complications. Functional health food.
  • a product for enhancing immunity and controlling diabetes comprising an active ingredient and an auxiliary material, the active ingredient being composed of the following components: 5-10 parts of Cordyceps militaris extract, 35-50 parts of Thousand Buddha extract, shiitake mushroom 20-30 parts of polysaccharide, 5-10 parts of puerarin isoflavone, 7-15 parts of medlar extract, and 8-20 parts of hamweed mushroom extract.
  • the active ingredient is composed of the following components: 5-8 parts of Cordyceps militaris extract, 40-45 parts of Thousand Buddha extract, 25-30 parts of lentinan, 6-8 parts of puerarin isoflavone, and 10-15 of medlar extract 10-18 parts of Coprinus comatus extract.
  • the active ingredient is composed of the following components: 6 parts of Cordyceps militaris extract, 40 parts of Thousand Buddha extract, 25 parts of lentinan, 7 parts of puerarin isoflavone, 10 parts of medlar extract, and 12 parts of Coprinus comatus extract.
  • the adjuvant contains a sweetener.
  • the sweetener is stevioside and is 0.2-0.5 parts by weight.
  • the dosage forms are in the form of tablets, capsules, granules, oral liquids, or beverages, tea bags.
  • the present invention adopts the principle of homologous medicine and medicine, and preferably selects the above-mentioned raw materials, and makes it into a functional health food, which is beneficial to enhance the immunity of the body, and at the same time
  • the above products have a good preventive and therapeutic effect on complications of diabetic patients.
  • Cordyceps militaris is the abbreviation of Cordyceps militaris, also known as Cordyceps militaris or valerian, common name is not old grass, is a medicinal fungus that combines insects and bacteria, modern rare Chinese herbal medicine, Cordyceps militaris belongs to fungi, Ascomycetes, and meat genus. Ergotaceae, Cordyceps.
  • Cordyceps militaris is rich in protein, 18 kinds of amino acids, 17 kinds of trace elements, 12 kinds of vitamins: A, Bl, B2, B6, B12, C, D, E, etc.
  • cordycepin can be used as an anticancer agent, an antiviral agent, an antioxidant, a ribonucleic acid inhibitor, a biologically active substance, an antifungal agent.
  • cordycepin The mechanism of action of cordycepin is a strong inhibitory effect on the proliferation of mouse tumor cell lines.
  • Cordycepin can infiltrate into RA and phosphorylate into 3-ATP in cells, which inevitably leads to mRNA absorption and maturation barriers. , affecting the synthesis of proteins, Thereby achieving the effect of inhibiting tumors.
  • the efficacy of Cordyceps sinensis 1, can significantly reduce the ability of mice to resist hypoxia, increase myocardial nutritional blood flow; maintain arrhythmia in rats; have a protective effect on myocardial infarction caused by stress. 2, lowering blood fat and preventing arteriosclerosis, has a comprehensive promotion of hematopoietic function. 3. Promote cellular immunity and inhibit humoral immunity. A novel immunosuppressive agent considered to be an effective element. 4. It has a certain inhibitory effect on mouse gastric cancer and lung cancer. The inhibition rate is 30% to 50%. Intraperitoneal injection has an inhibitory effect on Ehrlich ascites carcinoma and can inhibit carcinogenesis-induced anterior gastric epithelial hyperplasia. 5, there are male hormone-like effects.
  • Cardiovascular effects inhibit platelet aggregation.
  • CFU-3 bone marrow hematopoietic stem cells
  • CFU-E BFU-E red progenitor cells
  • CFU-E bone marrow fibroblast progenitor cells
  • silkworm Cordyceps has anti-fatigue, improve the body's immunity, kill cancer cells and so on.
  • Thousand Buddhas also known as ash tree, chestnut mushroom, porphyra, maitake (Griflola frondosaX yunnan, lotus, etc., belonging to Basidiomycotina, Phytophthora, non-Pleurotus, Polyporaceae, tree flower
  • the genus is a rare food and medicine dual-use bacteria.
  • the maiden is rich in nutrients, and its nutrient content is tested by the Institute of Nutrition and Food Hygiene of the Chinese Academy of Preventive Medicine and the Quality Inspection Center of the Ministry of Agriculture.
  • Maitake mushroom (Gray Tree Flower) is not only nutritious, but also has a good health care effect on the human body and anti-cancer, anti-cancer and anti-AIDS effects.
  • Maitake is used as a wild herb for the treatment of stomach, esophageal cancer, and breast cancer.
  • the oral ash tree flower has a suppression rate of more than 74%.
  • Professor Huang Xingyu from Zhejiang Medical University studied that the anti-cancer effect of Grifola frondosa is mainly B-glucan, accounting for more than 8% of Grifola frondosa. The research report of Prof.
  • Grifola frondosa contains a large amount of active substances, which can promote liver function, improve fat metabolism, thereby avoiding arteriosclerosis and inhibiting obesity. Symptoms, stabilize blood pressure. Grifola frondosa can promote healthy growth and mental development of children, and can prevent anemia, scurvy, bad blood, rickets and rickets. Grifola frondosa is rich in iron, zinc, calcium, phosphorus and various trace elements. Regular food can avoid a variety of nutritional deficiencies. The lysine content of ash tree flowers can promote children's healthy growth and mental development (accounting for 1.16).
  • Pueraria isoflavones are the main functional ingredients in Pueraria lobata extract.
  • Pueraria lobata contains various flavonoids: soy, soy, and soy, 4, 7-diglucoside, puerarin, puerarin-7-wood Glycosides, puerarin, puerarin and isoflavones, etc., the main role is to supplement female estrogen, suitable for adolescence, childbearing and postpartum women, menopausal women.
  • Pueraria isoflavones can shrink smooth muscle, increase coronary blood flow, inhibit platelet aggregation, and lower blood sugar.
  • Efficacy of Pueraria Isoflavones 1 Effect on Smooth Muscle Soybean aglycone in Pueraria has an anti-acetylcholine effect and can significantly contract smooth muscle, which is considered to be the main component of Pueraria lobata. 2 Effect on coronary circulation Pueraria decoction, alcohol extract, total flavonoids and puerarin have obvious effects of dilating coronary vessels, which can increase coronary blood flow and reduce vascular resistance.
  • Puerarin can also significantly reduce myocardial lactic acid caused by ischemia. Produce and improve the metabolism of infarcted myocardium. 5 Effects on blood pressure and peripheral blood vessels Pueraria radix ketone and puerarin can significantly reduce plasma renin activity and angiotensin, and blood pressure decreases. Puerarin has a significant improvement effect on microcirculatory disorders, mainly manifested by increased microvascular movement. Amplitude and increase local micro-blood flow; total flavonoids from Pueraria lobata have a significant effect on dilating cerebral blood vessels, improving brain microcirculation and peripheral circulation. It has been reported that puerarin can also improve the blockade of retinal vascular end units, thereby improving visual function.
  • puerarin can inhibit adenosine diphosphate (ADP) induction and 5- ⁇ (5-hydroxytryptamine) combined with ADP induced platelet aggregation in humans and animals; in addition, puerarin can also significantly inhibit the induction of thrombin
  • ADP adenosine diphosphate
  • 5- ⁇ 5-hydroxytryptamine
  • puerarin can also significantly inhibit the induction of thrombin
  • the release of 5-quinone in platelets has an antithrombotic effect.
  • the role of hypoglycemia Puerarin can counteract the agglutination of epinephrine and has a certain ability to lower blood sugar.
  • 8 Effect on body temperature The total flavonoids of Radix Puerariae have a long-lasting and obvious cooling effect on the increase of body temperature caused by endotoxin. It is often used in external fever and fever.
  • Lentinus edodes polysaccharide is an effective ingredient in mushroom extract.
  • Mushrooms are also known as citron, vertebral ear, sweet letter, winter glutinous rice, thick mushroom, flower mushroom, English Name: Lentinat Mushroom is rich in nutrients and delicious, and is regarded as the "king of mushrooms". It contains lentinan (structured as follows).
  • amino acids including 7 kinds of essential amino acids such as isoleucine, lysine, phenylalanine, methionine, threonine and proline. Bl, B2, PP and mineral salts.
  • Lentinus edodes polysaccharide is an effective active ingredient extracted from high-quality mushroom fruit body.
  • the main components of shiitake mushroom are polysaccharides and unsaturated fatty acids, and also contain a large amount of ergosterol and mycohol which can be converted into vitamin D. It can regulate the immune function of T cells in the human body, which can reduce the ability of methylcholine to induce tumors. Mushrooms have a strong inhibitory effect on cancer cells, with an inhibition rate of 97.5% for mouse sarcoma 180 and 80% for Ehrlich cancer.
  • Scorpion has been the top grade for nourishing and supporting people. It has the effect of prolonging the decline and resisting the old, so it is also known as "the old man.” It has the functions of nourishing liver and kidney, nourishing liver and clearing the eye. It is often used together with rehmannia, chrysanthemum, yam, hawthorn and other medicines. Scorpion is also a good solution for strengthening the body, replenishing the marrow, nourishing yin and tonifying the kidney, replenishing qi and calming the nerves, strengthening the body, and delaying aging. It has a remarkable effect on chronic hepatitis, central retinitis, optic atrophy, etc.; for diabetes, tuberculosis, etc.
  • scorpion contains a very rich camp, containing 4.49 grams of crude protein per 100 grams of fruit, 2.33 grams of crude fat, 9.12 grams of carbohydrates, 96 mg of carotenoids, 0.053 mg of thiamine, nuclear yellow. 0.137 mg, ascorbic acid 19.8 mg, betaine 0.26 mg, rich in potassium, sodium, calcium, magnesium, iron, copper, manganese, zinc and other elements, as well as 22 amino acids and multivitamins.
  • the ⁇ polysaccharide functional factor has a very important and multi-faceted health function:
  • Immunomodulation ⁇ Polysaccharide has a very significant immunomodulatory effect on non-specific immunity and specific immunity in mice, which can significantly enhance mouse spleen lymphocyte proliferation, delayed type hypersensitivity, and increase serum hemolysin content in mice. , mouse peritoneal macrophage chicken red blood cell function, mouse carbon clearance ability, and ability to significantly enhance antibody production.
  • Lycium barbarum polysaccharide has obvious hypoglycemic effect on experimental diabetes, the effective rate is up to 100%; and it has no effect on blood sugar in normal mice.
  • hypolipidemic effect ⁇ polysaccharide has a significant effect on the blood lipids of experimental hyperlipidemic rats, can significantly reduce serum cholesterol, triglyceride content, and has a higher effect on high-density lipoprotein.
  • the experimental results show that the polysaccharide has obvious regulation of blood lipids.
  • (4) Anti-aging effect Drosophila survival test showed that alfalfa polysaccharide can significantly prolong the average life expectancy and maximum life span of female and male fruit flies. It also significantly increased the role of SOD in mouse red blood cells and significantly reduced MDA.
  • animal and clinical trial results show that lycium barbarum polysaccharide can significantly enhance the cellular immune function of dethymus mice, and also has a certain recovery effect on mouse sexual function.
  • the polysaccharide can increase the muscle glycogen and liver glycogen reserve of experimental mice. Increasing the total activity of lactose deamination, accelerating the clearance of blood urea and lowering the blood lactate level after exercise can significantly prolong the swimming time of mice. Therefore, the polysaccharide can enhance the body's physical strength and quickly eliminate fatigue after exercise.
  • alfalfa extract can significantly prolong the survival time of animals under hypoxic conditions and under irradiation conditions.
  • Coprinus comatus is a common name for chicken leg mushrooms. It is named after chicken legs and meaty meat like chicken. It is a rare and rare product with commercial potential developed in recent years. It is known as "a rookie in bacteria”. Scientific name: Maotou ghost umbrella. Alias: Coprinus comatus, thorn mushroom Latin name: Copyinds comatus (MUII. Fr) Gray, classification status: belonging to Basidiomycetes, Agaric, Coprinus, Coprinus.
  • the chicken leg mushroom is flat, sweet and smooth, with clearing spirit, benefiting the spleen and stomach, helping digestion, increasing appetite and other effects.
  • Coprinus comatus also contains anti-cancer active substances and active ingredients for the treatment of diabetes. Long-term consumption has a good effect on lowering blood sugar concentration and treating diabetes, especially for treating acne.
  • the chicken leg mushroom Because of the nutrition, health care and therapeutic treatment, the chicken leg mushroom has the excellent characteristics of high protein and low fat. And color, fragrance, taste shape is good. According to the "Chinese Medicinal Fungi Picture Book" and other books, the hot water extract of Coprinus comatus has a inhibition rate of 100% and 90% for the sarcoma 180 and Ehrlich cancer.
  • the specific nutrients of dried koji mushroom are: total sugar content is 57.65%, reducing sugar is 53.54%, protein is 24.45%, crude fat is 2.82%, crude fiber is 2.78%, ash is 10.8%, and moisture is 0.2%. Because of its certain nutritional value and delicious taste, Coprinus comatus is favored by consumers, so the fresh product is 2-3 times higher than the price of oyster mushrooms. It is a rare edible fungus.
  • the main ingredient in stevioside is stevioside, which is widely used in various foods, beverages, medicines, and the chemical industry as a new type of sweetener. It can be said that almost all sugar products can be replaced with stevia to replace some sucrose or all of the chemical sweeteners such as saccharin.
  • the stevioside having a purity of 80% or more of stevioside is white crystal or powder, and has little hygroscopicity. Soluble in water, ethanol, and mixed with sucrose, fructose, glucose, maltose, etc., not only the stevia flavor is more pure, but the sweetness can be multiplied.
  • the sugar has poor heat resistance, is not easy to be lighted, and is very stable in the pH range of 3 to 10, and is easy to store.
  • the stability of the solution is good, and the heat treatment is still stable in the pH range of the general beverage food.
  • Stevioside has little change in semi-annual storage in sucrose-containing organic acid solution; it does not decompose in acid-base medium to prevent fermentation, discoloration and precipitation; it can reduce viscosity, inhibit bacterial growth and prolong product shelf life.
  • citric acid, malic acid, tartaric acid, lactic acid, and acid, amino acid it has a killing effect on the aftertaste of stevioside. Therefore, in combination with the above substances, it can play a flavoring effect and improve the sweetness quality of stevia.
  • Efficacy characteristics 1, high security. residents of stevioside origin (South America, Paraguay, Masi, etc.) have been eating for hundreds of years and have not found any poison. 2. Low calorific value. It is used to make low-calorie foods and beverages, and is very suitable for patients with diabetes, obesity, and arteriosclerosis.
  • Diabetic peripheral neuropathy is a typical pathological process of gastro-intestinal disease caused by choroidal lesions.
  • the qi and blood block in the collaterals is the key to the onset, and it runs through. Diabetes complicates the pathogenesis of blood stasis, and the enthusiasm and enthusiasm cement each other.
  • the product of the invention adopts the effects of Cordyceps militaris, Thousand Buddha, Puerarin isoflavones, medlar to lower blood fat and lower blood sugar, and has the functions of preventing arteriosclerosis, improving fat metabolism, smoothing blood circulation, cleaning and preventing stasis, To prevent and control the role of diabetes, and to prevent the occurrence of cardiovascular complications; the use of Cordyceps militaris, Thousand Buddha, lentinan to improve the immune system, so that people with diabetes improve their immunity, reduce the occurrence of complications; The medlar is a nourishing top grade.
  • Combining Cordyceps militaris can enhance the physical disability caused by kidney deficiency in diabetic patients, improve the anti-fatigue ability, improve the patient's exercise capacity, make the qi and tongs, the scorpion also protects the liver, and the eye disease is remarkable. Efficacy, prevention of eye disease complications; combined with high protein, low calorie mushrooms, Coprinus comatus as a nutrient, to enhance exercise, while getting a reasonable nutritional supplement, Coprinus comatus can also adjust the spleen and stomach, help digestion, reduce food accumulation .
  • the present invention selects the food combinations of the above-mentioned several medicines and foods to make the gas and blood vessels smooth, not only can enhance the body immunity, lower blood sugar, and at the same time, diabetic nephropathy, neuropathy, digestive tract diseases, oral diseases. Complications such as impotence, skin and joint diseases, and lower extremity arteriosclerosis obliterans have a good effect. Early and mild patients can better control the occurrence of diabetic complications.
  • the present invention is added with stevioside, and as a sweetener, it does not improve the blood sugar of the patient, and at the same time, when used in combination with other extracts, it has a flavoring effect and can appropriately extend the product. Shelf life.
  • the present invention is mainly used for oral administration, and can be formulated into conventional solid preparations including tablets, capsules, granules, pills, oral solutions, and the like.
  • Tablet refers to a solid preparation of tablets or shaped tablets which are mixed with a suitable excipient and a suitable excipient; the tablets are mainly oral tablets, and include tablets, sublingual tablets, oral patches, and chewable tablets. , dispersible tablets, soluble tablets, effervescent tablets, sustained release tablets, controlled release tablets and enteric coated tablets.
  • Capsule refers to a solid preparation filled with a drug or an auxiliary material filled in a hollow capsule or sealed in a soft capsule; the capsule can be classified into a hard capsule (commonly known as a capsule) and a soft capsule (a capsule according to its dissolution and release characteristics). ), sustained release capsules, controlled release capsules and enteric capsules.
  • Granules refer to pharmaceuticals and suitable excipients to form dry granular preparations having a certain particle size; granules can be divided into soluble particles (commonly known as granules), suspended granules, effervescent granules, enteric granules, sustained release granules and Controlled release granules, etc.
  • Pill means a spherical or spheroidal solid preparation which is uniformly mixed with a suitable excipient and is prepared by a suitable method; the pill includes a dropping pill, a sugar pill, a pellet, and the like.
  • mouth By solution is meant a clear liquid preparation in which the drug is dissolved in a suitable solvent for oral administration.
  • the preparation of the present invention can be produced by a conventional method in the field of the prior art, and various pharmaceutically acceptable carriers can be added as needed.
  • the carrier includes a conventional osmotic pressure adjusting agent, a pH adjusting agent, a solubilizing agent, an antioxidant, a bacteriostatic agent, an emulsifier, a suspending agent, a filler, a binder, a disintegrating agent, and a lubricant in the pharmaceutical field. Etc., is part of the excipients of the present invention.
  • a suitable filler, a binder, a disintegrant, a lubricant and the like may be added.
  • Fillers include starch, powdered sugar, calcium phosphate, calcium sulfate dihydrate, dextrin, microcrystalline cellulose, lactose, pregelatinized starch, mannitol, etc.; binders include sodium carboxymethylcellulose, PVP-K30 , hydroxypropyl cellulose, starch syrup, methyl cellulose, ethyl cellulose, hypromellose, gelatinized starch, etc.; disintegrants include dry starch, crospovidone, crosslinked carboxymethyl fiber Sodium, sodium carboxymethyl starch, low-substituted hydroxypropyl cellulose, etc.; lubricants include magnesium stearate, talc, sodium lauryl sulfate, micronized silica gel, and the like.
  • the product of the invention adopts Cordyceps militaris extract, Thousand Buddha extract, Lentinus edodes polysaccharide, Pueraria lobata extract, Lycium barbarum extract and Coprinus comatus extract as active ingredients thereof, so that sub-healthy people, immunocompromised people and diabetic patients It is a functional health food that can control the occurrence of diabetic complications and enhance the body's immunity while achieving blood sugar lowering.
  • Cordyceps militaris extract, Thousand Buddha extract, medlar extract and Coprinus comatus extract are extracted with water as a solvent, and extracted by conventional water extraction method of traditional Chinese medicine.
  • Lentinus edodes polysaccharide, puerarin isoflavone, stevioside is a commercially available product.
  • Cordyceps militaris extract 60g, Thousand Buddha extract 400g, lentinan 250g, Pueraria isoflavone 70g, medlar extract 100g, Coprinus comatus extract 120g, capsules were prepared according to conventional methods.
  • Cordyceps sinensis extract 80g Thousand Buddha extract 450g, Lentinus edodes 200g, Puerariae isoflavone 80g, Lycium barbarum extract 80g, Coprinus comatus extract 200g, mixed in lOOKg water, add appropriate amount of stabilizer, stevioside can be seasoned .
  • the health food prepared in the first embodiment has an active ingredient weight of 720 mg/d per day, which is 12 mg/kg body weight, based on 60 kg body weight of an adult.
  • Test animals Adult rats weighing 180g ⁇ 200g, male, 100 were purchased from Hubei Experimental Animal Research Center, and the certificate number is No. 2009-0810.
  • the experiment consists of three dose groups: 10 times human intake low dose group, 20 times human intake medium dose group, 30 times human intake high dose group and high blood glucose model control group .
  • the oral volume of the mice was 0.2 ml/10 g body weight.
  • the administration method is as follows: the mice are intravenously injected with alloxan 35 to 50 mg/kg body weight, and the rats are intravenously injected with alloxan 50 to 80 mg/kg body weight. After 5 ⁇ 7d, fasting for 3 ⁇ 5h, measuring blood sugar, blood glucose value reached 10 ⁇ 25mmol/L, which is successful modeling.
  • Glucose oxidase is an aerobic dehydrogenase that catalyzes the production of glucose by gluconic acid and hydrogen peroxide. The latter releases oxygen under the action of peroxidase, which in turn oxidatively condenses 4-aminoantipyrine with a phenol to form a red terpenoid which can be measured by colorimetric at a wavelength of 505 nm.
  • Enzymes glucose oxidase 400U, peroxidase 0.6mg, 4-aminoantipyrine 10mg, sodium azide lOOmg, phosphate buffer to lOOmL, pH adjusted to 7.
  • the refrigerator can be stored for at least 2 months.
  • Phenol reagent Dissolve 100 mg of phenol in 100 mL of distilled water.
  • Enzyme mixing reagent Mix the same amount of enzyme reagent and phenol reagent. It can be stored in the refrigerator for 1 month.
  • Glucose standard stock solution Anhydrous D-glucose (AR) is baked in an oven at 80 ° C for 4 h, cooled and stored in a desiccator to constant weight. Accurately weigh 2g, dissolve it in 0.25% benzoic acid solution, transfer it to a lOOmL volumetric flask, and dilute to 100mL with benzoic acid solution.
  • AR anhydrous D-glucose
  • Protein precipitant Dissolve 10 g of disodium hydrogen phosphate, 10 g of sodium tungstate, 9 g of sodium chloride in 800 mL of distilled water, add 125 mL of 1 mol/L hydrochloric acid, and dilute to 1000 mL with distilled water. 1.3.3 Operation steps
  • AA 2 represents the absorbance values of the measuring tube and the standard tube, respectively.
  • Table 2 The experimental results of the hypoglycemic functional animals of the health food are shown in Table 2:
  • Test group On the basis of the original treatment, the hypoglycemic agent was deactivated, and the health food prepared in Example 4 of the present invention was used. The recommended amount of the active ingredient per adult was 720 mg/d o per day, which is 12 mg/kg body weight.
  • Control group According to the conventional hypoglycemic treatment, the dosages of the hypoglycemic drugs and the varieties were matched with the test.
  • the fasting blood glucose was regularly checked by the same method, and the observation period was three months, and one month was a course of treatment. A total of three courses.
  • the criteria for determining the blood sugar lowering function health food can be judged that the human body experiment results of the health food product indicate that the blood sugar lowering function is obvious.
  • Example 3 We also measured the immune function of the test diabetic patients before and after taking the health food prepared in Example 4 of the present invention. Relevant data, and compared with normal people, the results are shown in Table 4.
  • the method for detecting the tau cell subset is to use a conventional alkaline phosphatase anti-alkaline phosphatase method.
  • the measurement data showed that the okT 3 was significantly higher than that of the normal person before taking the drug of the present invention, and the okT 4 /okT 3 ratio was significantly decreased. After taking the health food of the present invention, both of them substantially returned to normal, indicating that the health food of the present invention has Enhance the body's immune function.
  • Test material The product of the invention obtained in Example 3 of the present invention; the recommended amount for adults is 2 g/d per day. According to the adult 60kg body weight, that is, 33mg / (kg * body weight).
  • Test animals Clean grade BALB / c mice, male, 200, 18 ⁇ 22g, purchased from Hubei Experimental Animal Research Center, and the syndrome number is No. 2006-0812.
  • Dose selection The experiment consists of three dose groups: 10 times human intake [0.33g / (kg * weight)] group, 20 times human intake
  • mice [0.67g / (kg * body weight)] group, 30 times human intake [l.OOg / (kg * body weight)] group and control group.
  • the volume of the mice was 0.2 ml / 10 g ⁇ body weight.
  • DTH delayed type hypersensitivity
  • mice were removed from the eyeball and blood was taken from the centrifuge tube, placed for about 1 h, the serum was precipitated, centrifuged at 2000 r / min for 10 min, and serum was collected.
  • the serum was diluted with physiological saline (300 times), and the diluted serum 1 mL was placed in a test tube, and 10% (volume fraction) SRBC 0.5 mL, 1 mL of complement (diluted 1:10 with physiological saline) was added in sequence, and no serum was added.
  • control tube (replaced with physiological saline) was incubated in a constant temperature water bath at 37 ° C for 15 to 30 minutes, and then the reaction was terminated by an ice bath. Centrifuge at 2000r / min for 10 min, take 1 mL of the supernatant, add 3 mL of Dud reagent to the test tube, and take 10% (volume fraction) SRBC 0.25 ml Addition of Dud reagent to 4 mL. Mix in another tube and mix thoroughly. After lOmin was placed, the control tube was blanked at 540 nm, and the optical density values of the respective tubes were measured.
  • Antibody-producing cell assay Take the spleen of mice after 5 days of SRBC immunization, place in a small dish containing Hanks liquid, gently grind the spleen, and filter through a 200 mesh screen. Into a single cell suspension. After centrifugation for 10 min (1000 r/min), the cells were washed twice with Hanks, and the cells were suspended in 5 mL of RPMI 1640 medium, the cells were counted, and the cell concentration was adjusted to 5 ⁇ 10 6 /mL.
  • mice peritoneal macrophage phagocytosis chicken red blood cell experiment (half-in vivo method): After the test material was continuously administered to mice for 30 days, each mouse was intraperitoneally injected with 2% chicken red blood cell suspension lmL. After 30 minutes, the animal was sacrificed by cervical dislocation. The animal was fixed on the wax plate in the supine position. The skin of the abdominal wall was cut in the middle. 2 mL of normal saline was injected into the abdominal cavity, and the mouse plate was rotated for 1 min. Then, 1 mL of the peritoneal washing solution was aspirated, and the average was divided into 2 slides. Place in an enamel box with wet gauze and incubate at 37 °C for 30 min.
  • 1.5.5ConA-induced spleen lymphocyte transformation test and mouse NK cell activity assay (lactate dehydrogenase LDH assay): After the test material was given to the mice for 30 days, the cervical vertebrae were dislocated and the spleen was aseptically taken. Place in a small plate filled with appropriate amount of sterile Hanks solution, gently smash the spleen with tweezers, filter through a 200 mesh sieve, and make a single cell suspension. The cell suspension is divided into two parts and induced in ConA. Mouse spleen lymphocyte transformation assay and mouse NK cell activity assay.
  • the cells were suspended in 1 mL of complete medium, and the number of viable cells (over 95%) was counted by trypan blue staining, and the cell concentration was adjusted to 3 ⁇ 10 6 cells/mL.
  • Each cell suspension was added to a 24-well culture plate in two wells, 1 mL per well, one well was added with 75 uL of ConA solution, and the other well was used as a control, and cultured in an incubator for 72 hours. 4 h before the end of the culture, 0.7 mL of the supernatant was aspirated per well, and 0.7 mL of serum-free RPMI 1640 medium was added thereto, and MTT 50 uL/well was added thereto, and the culture was continued for 4 hours.
  • mice NK cell activity (Lactate dehydrogenase LDH assay): The target cells were subcultured 24 h before the test, washed three times with Hanks before application, and adjusted to a cell concentration of 4 X 10 with RPMI 1640 complete medium. 5 / mL. The spleen cell suspension was washed twice with Hanks solution and centrifuged for 10 min (1000 r/min) each time.
  • target cells and effector cells Take 100uL of target cells and effector cells (effective target ratio 50: 1), and add to 96-well culture plates; target cells naturally release wells plus target cells and 1% NP 40 each 100uL, each of which has three replicate wells. Incubate in a 37 ° C, 5% CO 2 incubator for 4 h, then centrifuge the plate (1500 r / min) for 5 min, take the supernatant lOOuL per well into a 96-well culture plate, add LDH substrate solution 100uL, reaction for 3min 1 mol/L of HCI 30 uL was added to each well, and the optical density value was measured at 490 nm. Experimental data statistics: The experimental data were analyzed using SAS software.
  • Control group 10 18.4 ⁇ 1.3 22.3 + 1.2 3.9 ⁇ 0.8
  • Control group 10 18.5 ⁇ 1.4 22.3+ 1.5 3.8 ⁇ 1.0
  • Q test the 30-fold dose group recommended by the human body was significantly different from the control group, P ⁇ 0.05.
  • mice 2.3 The effect of the product of the present invention on mouse cellular immune function [mouse spleen lymphocyte transformation experiment and mouse delayed type hypersensitivity (DTH)] is shown in Table 11.
  • Table 11 Effect of the product of the present invention on cellular immune function of mice (X Shi S)
  • F The degree of ear swelling
  • F 3.42, P ⁇ 0.05.
  • the 30-fold dose group of the human body recommended was compared with the control group, P ⁇ 0.05, and there was a significant difference.
  • Control group 10 264 ⁇ 60 155.08 ⁇ 9.88
  • Q test the three dose groups compared with the control group, there was a significant difference, P ⁇ 0.05; HC 5 .
  • F 4.88, P ⁇ 0.01.
  • Q test 30 times the dose group compared with the control group, there was a significant difference, P ⁇ 0.01.
  • Control group 10 23.1 ⁇ 4.8 0.35 ⁇ 0.05
  • the mouse cell immune function test showed that in the realization of spleen lymphocyte transformation, the 0D difference of the three dose groups recommended by the human body of the present invention was significantly higher than that of the control group, and the positive result was obtained; the delayed type allergic reaction experiment showed that Compared with the control group, the degree of ear swelling was significantly different between the 30-fold dose group and a positive result.
  • mice showed that in the antibody-producing cell experiment, compared with the control group, the number of hemolytic plaques in the spleen cells of the three dose groups of the present invention was significantly increased, and the positive result was obtained; assay showed that, HC 5 30 times dose group. The value was significantly different from the control group and showed a positive result.
  • mice monocyte-macrophage function test showed that the phagocytic index of the 30-fold dose group of the present invention was significantly higher than that of the control group in the mouse carbon clearance test; the mouse macrophage phagocytosis Chicken red blood cell test showed that the phagocytic index of the 30-fold dose group was significantly higher than that of the control group, showing a positive result.
  • the NK cell activity assay showed that the activity of NK cells in the 30-fold dose group of the present invention was significantly higher than that of the control group, and a positive result was obtained.
  • the basic cure criteria more than three symptoms disappeared, the test fasting blood glucose is normal, urine sugar is negative.
  • Typical case 2 Ding XX, female, 48 years old, suffering from diabetes for 5 years, then check the fasting blood glucose 12. 8mmol / L, two hours after the meal, blood glucose 19. 5mmol / L urine sugar (+ + +), weight loss from 130 kg To 100 kilograms, feeling boring, polydipsia, polydipsia, polyuria, polyphagia, and blurred vision, after taking metformin, mebida, sugar and equal hypoglycemic agents, blood sugar control is basically normal, because of fear of Western medicine Liver and kidney are damaged, there is always a psychological burden, I hope to take Chinese medicine treatment. In November 2009, I went to Beijing to go to the door. After a friend introduced the effect of the health food, I started taking it.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A functional health food product that enhances organ immunity and controls diabetes comprises active ingredients and auxiliary material. The active ingredients consist of the following: 5 to 10 parts of cordyceps militaris extracts, 35 to 50 parts of grifola frondosa extracts, 20 to 30 parts of lentinan, 5 to 10 parts of pueraria isoflavone, 7 to 15 parts of fructus lycii extracts, and 8 to 20 parts of coprinus comatus. For people in conditions of sub-health, with low immunity or having diabetes, the present product promotes meridian energy flow, lowers blood sugar, controls the onset of diabetic complications, and enhances organ immunity.

Description

说明书  Instruction manual
一种增强机体免疫力并能控制糖尿病的产品 技术领域 A product that enhances immunity and can control diabetes
本发明涉及功能保健食品领域, 特别是涉及一种增强机体免疫力并能控制糖尿病的产品。 背景技术 糖尿病是一种常见的慢性病。 随着人们生活水平的提高, 人口老龄化以及肥胖发生率的增加, 糖尿病的发病率呈逐年上升趋势。根据贾春宝糖尿病足研究院的报告显示: 目前, 我国糖尿病的发 病率达到 3%有余, 已确诊的糖尿病患者达 4500万, 并以每年约 150万的速度递增。 糖尿病是一种终身性疾病,其严重性在于并发症的发生率较高。人们开始对糖尿病都不太重视, 据而出现并发症, 后果相当严重。 足病、 肾病、 眼病、 脑病、 心脏病、 皮肤病、 性病是糖尿病最常 见的并发症。 美国的研究表明, 患糖尿病 20年以上的病人中有 95%出现视网膜病变, 糖尿病患者 死于心血管疾病。 除此之外, 糖尿病患者还可能并发肾病、 神经病变、 消化道疾病、 口腔疾病、 阳 痿、皮肤和关节疾病以及下肢动脉硬化闭塞症等。 由于糖尿病并症可以累及全身各个系统, 因此给 糖尿病患者精神和肉体上都带来很大的痛苦,而避免和控制糖尿病并发症的最好办法就是控制血糖 水平。  The invention relates to the field of functional health foods, in particular to a product which enhances immunity of the body and can control diabetes. BACKGROUND OF THE INVENTION Diabetes is a common chronic disease. With the improvement of people's living standards, the aging of the population and the increase in the incidence of obesity, the incidence of diabetes is increasing year by year. According to the report of Jia Chunbao Diabetes Research Institute: At present, the incidence of diabetes in China has reached more than 3%, and the number of diagnosed diabetes patients has reached 45 million, and the rate has increased by about 1.5 million per year. Diabetes is a lifelong disease whose severity is due to a high incidence of complications. People began to pay less attention to diabetes, and complications occurred, and the consequences were quite serious. Podiatry, kidney disease, eye disease, encephalopathy, heart disease, skin disease, and sexually transmitted diseases are the most common complications of diabetes. Studies in the United States have shown that 95% of patients with diabetes for more than 20 years have retinopathy, and those with diabetes die from cardiovascular disease. In addition, people with diabetes may also have kidney disease, neuropathy, digestive tract disease, oral disease, impotence, skin and joint diseases, and lower extremity arteriosclerosis obliterans. Because diabetes can affect all systems of the body, it can cause great mental and physical pain to diabetic patients. The best way to avoid and control diabetes complications is to control blood sugar levels.
目前临床上常用的口服降糖药都有副作用, 均可引起消化系统的不良反应, 有些还引起麻疹, 贫血, 白细胞和血小板减少, 头晕和乏力等。 因此寻找开发具有增强机体免疫力作用的保健食品, 以辅助药物治疗, 在有效地控制血糖和糖尿病并发症的同时降低副作用已引起人们的关注。  At present, oral hypoglycemic drugs commonly used in clinical practice have side effects, which can cause adverse reactions in the digestive system, and some cause measles, anemia, leukopenia and thrombocytopenia, dizziness and fatigue. Therefore, the search for the development of health foods that enhance the immunity of the body to assist in drug treatment has been attracting attention while effectively controlling blood sugar and diabetic complications while reducing side effects.
糖尿病的各种并发症随时危机着病人的健康, 糖尿病人也希望能尽快摆脱如此困境。 目前, 合 理的饮食与营养仍然是预防和控制糖尿病及其并发症的重要手段。 尽管糖尿病可能引发各种并发 症, 专家们指出, 只要及时干预, 完全可以起到预防并延迟并发症的效果, 尤其要改变现代人 "出 门就打的, 进门找电梯" 的生活方式。 专家强调, 无论糖尿病, 还是心血管并发症, 基因遗传的影 响只占 10%, 90%是后天不健康的生活方式造成的, 比如吸烟、 运动少、 饮食不合理、 精神紧张等。 糖尿病并发症有无或其严重程度对糖尿病患者的生命及预后起着决定性作用,因此每位糖尿病患者 为能长寿, 应采取有效的措施预防合并症的发生。我国中医技术源远流长, 老百姓也非常讲究饮食 文化, 在药物治疗的同时, 用食物辅助、 加强疗效, 是民间常用的方法, 但市场上还没有见到此类 较好的降血糖疗效的保健食品。 Diabetes people are hoping to get rid of this dilemma as soon as possible. At present, reasonable diet and nutrition are still important means to prevent and control diabetes and its complications. Although diabetes may cause various complications, experts pointed out that as long as timely intervention, it can completely prevent and delay the effects of complications, especially to change the lifestyle of modern people who "go out and hit the door to find the elevator". Experts stressed that regardless of diabetes, or cardiovascular complications, genetic inheritance only accounts for 10%, 90% is caused by unhealthy lifestyles such as smoking, exercise, irrational diet, and nervousness. The presence or absence of diabetes complications or its severity plays a decisive role in the life and prognosis of diabetic patients. Therefore, for each diabetic patient to have longevity, effective measures should be taken to prevent the occurrence of comorbidities. Chinese traditional Chinese medicine technology has a long history. The common people also pay great attention to food culture. At the same time of drug treatment, food supplementing and strengthening curative effect are common methods used by the people. However, there is no such healthy food for lowering blood sugar curative effect.
发明内容 Summary of the invention
针对上述领域中的缺陷,本发明提供一种增强机体免疫力并能控制糖尿病的产品,其原料完全 符合药食同源标准,是一种能增强机体免疫力,并能辅助药物控制糖尿病并发症的功能性保健食品。  In view of the defects in the above-mentioned fields, the present invention provides a product for enhancing immunity and controlling diabetes, and the raw material completely conforms to the homologous standard of medicine and food, and is capable of enhancing immunity of the body and assisting in controlling diabetes complications. Functional health food.
一种增强机体免疫力并能控制糖尿病的产品, 由有效成分和辅料组成,所述有效成分由如下组 分组成: 北虫草提取物 5-10份, 千佛菌提取物 35-50份, 香菇多糖 20-30份, 葛根异黄酮 5-10份, 枸杞提取物 7-15份、 鸡腿菇提取物 8-20份。  A product for enhancing immunity and controlling diabetes, comprising an active ingredient and an auxiliary material, the active ingredient being composed of the following components: 5-10 parts of Cordyceps militaris extract, 35-50 parts of Thousand Buddha extract, shiitake mushroom 20-30 parts of polysaccharide, 5-10 parts of puerarin isoflavone, 7-15 parts of medlar extract, and 8-20 parts of hamweed mushroom extract.
所述有效成分由如下组分组成:北虫草提取物 5-8份,千佛菌提取物 40-45份,香菇多糖 25-30 份, 葛根异黄酮 6-8份, 枸杞提取物 10-15份、 鸡腿菇提取物 10-18份。  The active ingredient is composed of the following components: 5-8 parts of Cordyceps militaris extract, 40-45 parts of Thousand Buddha extract, 25-30 parts of lentinan, 6-8 parts of puerarin isoflavone, and 10-15 of medlar extract 10-18 parts of Coprinus comatus extract.
所述有效成分由如下组分组成: 北虫草提取物 6份, 千佛菌提取物 40份, 香菇多糖 25份, 葛 根异黄酮 7份, 枸杞提取物 10份、 鸡腿菇提取物 12份。  The active ingredient is composed of the following components: 6 parts of Cordyceps militaris extract, 40 parts of Thousand Buddha extract, 25 parts of lentinan, 7 parts of puerarin isoflavone, 10 parts of medlar extract, and 12 parts of Coprinus comatus extract.
所述辅料中含有甜味剂。  The adjuvant contains a sweetener.
所述甜味剂为甜菊糖甙, 重量份为 0.2-0.5份。  The sweetener is stevioside and is 0.2-0.5 parts by weight.
所述辅料中有赋形剂。  There are excipients in the excipients.
其剂型形式为片剂、 胶囊剂、 颗粒剂、 口服液, 或者饮料、 袋泡茶。  The dosage forms are in the form of tablets, capsules, granules, oral liquids, or beverages, tea bags.
根据背景技术的分析, 糖尿病多数为饮食不当造成的, 本发明采用药食同源的道理, 优选了上 述几种原料, 将其制成功能性保健食品, 经常饮用有利于增强机体免疫力, 同时上述产品对糖尿病 患者的并发症有较好的预防和治疗作用。  According to the analysis of the background art, most of the diabetes is caused by improper diet. The present invention adopts the principle of homologous medicine and medicine, and preferably selects the above-mentioned raw materials, and makes it into a functional health food, which is beneficial to enhance the immunity of the body, and at the same time The above products have a good preventive and therapeutic effect on complications of diabetic patients.
1、 北虫草 1, Cordyceps
北虫草是北冬虫草的简称, 也叫蛹虫草或蛹草, 俗名不老草, 是虫, 菌结合的药用真菌, 现代 珍稀中草药, 北冬虫夏草属于真菌门, 子囊菌纲, 肉座菌目, 麦角菌科, 虫草属。 北冬虫夏草含有 丰富的蛋白质、 18种氨基酸、 17种微量元素、 12种维生素: A、 Bl、 B2、 B6、 B12、 C、 D、 E 等含量高于菇类, 北冬虫夏草中虫草素的含量为 0.536克, 而野生的虫草中虫草素的含量为 0.006 克;虫草素可用于抗癌剂、 抗病毒剂、 抗氧化剂、 核糖核酸抑制剂、 生物活性物质、 抗真菌剂。  Cordyceps militaris is the abbreviation of Cordyceps militaris, also known as Cordyceps militaris or valerian, common name is not old grass, is a medicinal fungus that combines insects and bacteria, modern rare Chinese herbal medicine, Cordyceps militaris belongs to fungi, Ascomycetes, and meat genus. Ergotaceae, Cordyceps. Cordyceps militaris is rich in protein, 18 kinds of amino acids, 17 kinds of trace elements, 12 kinds of vitamins: A, Bl, B2, B6, B12, C, D, E, etc. are higher than mushrooms, and the content of cordycepin in Cordyceps militaris is 0.536 g, and the content of cordycepin in wild Cordyceps is 0.006 g; cordycepin can be used as an anticancer agent, an antiviral agent, an antioxidant, a ribonucleic acid inhibitor, a biologically active substance, an antifungal agent.
虫草素的作用机理,是对小鼠肿瘤细胞系细胞的增殖有很强的抑制作用,虫草素可渗入到 R A 中, 在细胞内可磷酸化为 3 -ATP, 因而势必导致 mRNA吸收和成熟障碍, 影响蛋白质的合成, 从而达到抑制肿瘤的作用。 The mechanism of action of cordycepin is a strong inhibitory effect on the proliferation of mouse tumor cell lines. Cordycepin can infiltrate into RA and phosphorylate into 3-ATP in cells, which inevitably leads to mRNA absorption and maturation barriers. , affecting the synthesis of proteins, Thereby achieving the effect of inhibiting tumors.
北虫草的功效: 1、 能明显减少小鼠耐缺氧能力, 增加心肌营养性血流量; 维持大鼠心律失常; 对应激引起的大鼠心肌梗塞有一定保护作用。 2、 降血脂及防动脉硬化, 对造血功能有全面的促进 作用。 3、 促进细胞免疫而抑制体液免疫。 认为是一种有效元素的新型免疫抑制剂。 4、 对小鼠胃癌 肺癌有一定抑制作用。 抑制率为 30%〜50%。 腹腔注射对艾氏腹水癌有抑制作用, 并能抑制癌物质 诱发的前胃上皮增生癌变。 5、 有雄性激素样作用。 通过性腺内分泌发挥作用外, 还可能通过神经 系统或其它方面起作用。 6、 心血管的作用抑制血小板聚集。 7、 促进骨髓造血干细胞 (CFU-3 )、 红细祖细胞 (CFU-E BFU-E) 及骨髓成纤维祖细胞 (CFU-E) 的增殖。 8、 蚕蛹虫草具有抗疲劳、 提高机体免疫力、 杀灭癌细胞等作用。  The efficacy of Cordyceps sinensis: 1, can significantly reduce the ability of mice to resist hypoxia, increase myocardial nutritional blood flow; maintain arrhythmia in rats; have a protective effect on myocardial infarction caused by stress. 2, lowering blood fat and preventing arteriosclerosis, has a comprehensive promotion of hematopoietic function. 3. Promote cellular immunity and inhibit humoral immunity. A novel immunosuppressive agent considered to be an effective element. 4. It has a certain inhibitory effect on mouse gastric cancer and lung cancer. The inhibition rate is 30% to 50%. Intraperitoneal injection has an inhibitory effect on Ehrlich ascites carcinoma and can inhibit carcinogenesis-induced anterior gastric epithelial hyperplasia. 5, there are male hormone-like effects. In addition to its role in gonadal endocrine, it may also work through the nervous system or other aspects. 6. Cardiovascular effects inhibit platelet aggregation. 7. Promote the proliferation of bone marrow hematopoietic stem cells (CFU-3), red progenitor cells (CFU-E BFU-E) and bone marrow fibroblast progenitor cells (CFU-E). 8, silkworm Cordyceps has anti-fatigue, improve the body's immunity, kill cancer cells and so on.
2、 千佛菌 2, thousand bacteria
千佛菌又名灰树花、 栗子蘑、 贝叶多孔菌、 舞茸(Griflola frondosaX 云蕈、 莲花菌等,属担子 菌亚门、 层菌纲、 非褶菌目、 多孔菌科、 树花菌属, 是一种珍稀的食、 药两用菌。 舞茸营养丰富, 其营养素含量经中国预防医学科学院营养与食品卫生研究所和农业部质检中心检测,每一百克干舞 茸中含有蛋白质 25.2克 (其中含有人体所需 18种氨基酸 18.68克,其中必需基酸占 45.5%) ,脂肪 3.2克、 膳食纤维 33.7克、 碳水化合物 21.4克、 灰分 5.1克, 富含钾、 磷、 铁、 锌、 钙、 铜、 硒、 铬等多种有益的矿物质, 维生素含量丰富, VE109.7毫克、 VB11.47毫克、 VB20.72毫克、 VC17.0 毫克、 胡萝卜素 4.5毫克, 多种营养素居各种食用菌之首,其中 VB1和 VE含量约高 10〜20倍, VC 含量是其同类的 3〜5倍,蛋白质和氨基酸是香菇的 2倍,能促进儿童身体健康成长和智力发育,有关的 精氨酸和赖氨酸含量较金针菇中赖氨酸 (1.024%)和精氨酸 (1.231%)的含量高, 与鲜味有关的门冬氨 酸和谷氨酸含量较高,因此被誉为 "华北人参"甚至"真菌之王"。  Thousand Buddhas, also known as ash tree, chestnut mushroom, porphyra, maitake (Griflola frondosaX yunnan, lotus, etc., belonging to Basidiomycotina, Phytophthora, non-Pleurotus, Polyporaceae, tree flower The genus is a rare food and medicine dual-use bacteria. The maiden is rich in nutrients, and its nutrient content is tested by the Institute of Nutrition and Food Hygiene of the Chinese Academy of Preventive Medicine and the Quality Inspection Center of the Ministry of Agriculture. Contains 25.2 grams of protein (which contains 18.68 grams of 18 amino acids required by the human body, 45.5% of which are essential acids), 3.2 grams of fat, 33.7 grams of dietary fiber, 21.4 grams of carbohydrates, 5.1 grams of ash, and is rich in potassium, phosphorus, and iron. , zinc, calcium, copper, selenium, chromium and other beneficial minerals, rich in vitamins, VE109.7 mg, VB11.47 mg, VB20.72 mg, VC17.0 mg, carotene 4.5 mg, various nutrients It is the first of all kinds of edible fungi, in which the content of VB1 and VE is about 10~20 times higher, the VC content is 3~5 times of its kind, and the protein and amino acid are twice as much as the mushroom, which can promote the healthy growth and wisdom of children. The development of the force, the content of arginine and lysine is higher than the content of lysine (1.024%) and arginine (1.231%) in Flammulina velutipes, and the content of aspartic acid and glutamic acid related to umami. High, so it is known as "North China Ginseng" or even "King of Fungi".
舞茸 (灰树花)不仅营养丰富,而且对人体还有很好的医疗保健作用和抗癌、防癌、预防艾滋病作 用。 在日本利用舞茸作为野生草药, 用于治疗胃部、 食道癌、 乳腺癌。 根据日本森宽一先生等人研 究, 人体口服灰树花对乳腺癌抑制率达 74%以上。 浙江医科大学黄幸纾教授研究, 灰树花的抑癌 作用主要是 B-葡聚糖, 在灰树花中占 8%以上。 日本神户女子药物大学难波宏彰教授的研究报告均 证实了灰树花对 HIV (艾滋病) 毒的抵抗作用。 给美国的感染者每日口服葡聚糖或灰树花粉 3公 斤, 其结果表明, 给药 60天, 50%的患者辅助 T淋巴细胞增加, 50%的患者辅助 T淋巴细胞停止 下降, 因此可以预测, 灰树花可以抑制或改善艾滋病的相关症状。 此外, 灰树花富含有机硒, 可作 为补硒食品, 若长期食用几乎可防止一切癌变。 灰树花还可抑制高血压和肥胖症, 预防动脉硬化。 灰树花中含有大量的活性物质, 能促使肝功能增强, 改善脂肪代谢, 从而避免动脉硬化, 抑制肥胖 症, 稳定血压。 灰树花可以促进儿童健康成长和智力发育, 可以预防贫血、 坏血症、 坏血、 佝偻病 和软骨病。 灰树花中富含水量铁、 锌、 钙、 磷及多种微量元素, 常食可以避免多种营养缺乏症, 灰 树花中能促进儿童身体健康成长和智力发育的赖氨酸含量 (占 1.16%) 和精氨酸 (1.25%),对妊娠哺 乳期妇女和儿童食用效果尤其显著, 可以使胎儿智力发育,使婴儿聪明健壮,因此被称为"立子蘑"。 在防治糖尿病方面, 灰树花中的有机铬能协助胰岛素维持正常的糖耐量,对肝硬化、 糖尿病均有效 果。 此外灰树花对增强免疫力、 促进生长、 延缓衰老、 增加记忆力和灵敏度、 保持皮肤光滑都有较 好作用。 Maitake mushroom (Gray Tree Flower) is not only nutritious, but also has a good health care effect on the human body and anti-cancer, anti-cancer and anti-AIDS effects. In Japan, Maitake is used as a wild herb for the treatment of stomach, esophageal cancer, and breast cancer. According to research by Mr. Sen Kuanyi and others, the oral ash tree flower has a suppression rate of more than 74%. Professor Huang Xingyu from Zhejiang Medical University studied that the anti-cancer effect of Grifola frondosa is mainly B-glucan, accounting for more than 8% of Grifola frondosa. The research report of Prof. Hongbo, Professor of the Kobe Women's Pharmaceutical University in Japan confirmed the resistance of Grifola frondosa to HIV (AIDS). Infected people in the United States daily oral administration of dextran or ash pollen 3 kg, the results showed that 50% of patients with adjuvant T lymphocytes increased for 60 days, 50% of patients help T lymphocytes stop falling, so can It is predicted that Grifola frondosa can suppress or improve the symptoms associated with AIDS. In addition, the ash tree flower is rich in organic selenium, which can be used as a selenium-enriched food. If it is eaten for a long time, it can prevent almost all cancers. Grifola frondosa also inhibits hypertension and obesity and prevents arteriosclerosis. Grifola frondosa contains a large amount of active substances, which can promote liver function, improve fat metabolism, thereby avoiding arteriosclerosis and inhibiting obesity. Symptoms, stabilize blood pressure. Grifola frondosa can promote healthy growth and mental development of children, and can prevent anemia, scurvy, bad blood, rickets and rickets. Grifola frondosa is rich in iron, zinc, calcium, phosphorus and various trace elements. Regular food can avoid a variety of nutritional deficiencies. The lysine content of ash tree flowers can promote children's healthy growth and mental development (accounting for 1.16). %) and arginine (1.25%) are particularly effective for pregnant and lactating women and children, which can make the fetus mentally develop and make the baby smart and strong, so it is called "Zizi Mushroom". In the prevention and treatment of diabetes, organic chromium in Grifola frondosa can help insulin maintain normal glucose tolerance, and has effects on cirrhosis and diabetes. In addition, Grifola frondosa has a good effect on enhancing immunity, promoting growth, delaying aging, increasing memory and sensitivity, and keeping skin smooth.
3、 葛根异黄酮 3, Pueraria Isoflavone
葛根异黄酮为葛根提取物中的主要功效成分, 葛根中含有多种黄酮类物质: 大豆素, 大豆甙, 还有大豆素 -4, 7-二葡萄糖甙, 葛根素, 葛根素 -7-木糖甙, 葛根醇, 葛根藤及异黄酮甙等, 主要作 用是补充女性雌激素, 适用于青春期、育龄期及产后女性、 更年期女性等。 葛根异黄酮能够收縮平 滑肌、 增加冠血流量、 抑制血小板凝集、 降血糖等作用。  Pueraria isoflavones are the main functional ingredients in Pueraria lobata extract. Pueraria lobata contains various flavonoids: soy, soy, and soy, 4, 7-diglucoside, puerarin, puerarin-7-wood Glycosides, puerarin, puerarin and isoflavones, etc., the main role is to supplement female estrogen, suitable for adolescence, childbearing and postpartum women, menopausal women. Pueraria isoflavones can shrink smooth muscle, increase coronary blood flow, inhibit platelet aggregation, and lower blood sugar.
葛根异黄酮的功效作用: 1 对平滑肌的作用 葛根中的大豆甙元具有抗乙酰胆碱作用,能够明 显收縮平滑肌, 被认为是葛根解痉作用的主要成分。 2 对冠状循环的作用 葛根水煎剂、 醇浸膏、 总黄酮和葛根素均有明显的扩张冠状血管的作用, 能使冠血流量增加, 血管阻力降低。 3 对心肌梗 塞和心律失常的作用 葛根醇浸膏、 大豆甙元和葛根素均有明显的对抗乌头碱和氯化钡诱发的心律 失常作用, 葛根素还能明显縮短氯彷、 肾上腺素诱发的家兔心律失常时间, 葛根素能明显縮小心肌 梗塞范围, 被认为是一种 β-肾上腺素受体阻滞剂。 4 对心脏功能和心肌代谢的影响 葛根总黄酮和 葛根素能减慢心率, 降低心脏总外周阻力, 减少心肌耗氧量; 提高心肌工作效率.葛根素还能明显 减少缺血引起的心肌乳酸的产生,改善梗塞心肌的代谢。 5 对血压和外周血管的作用 葛根总葛酮 和葛根素能使血浆肾素活性和血管紧张素显著降低, 血压下降.葛根素对微循环障碍有明显的改善 作用,主要表现为增加微血管运动的振幅和提高局部微血流量;葛根总黄酮具有明显扩张脑血管的 作用, 改善脑微循环和外周循环.据报道, 葛根素还能改善视网膜血管末稍单位的阻滞状态, 从而 提高视功能。 6 抑制血小板聚集作用 葛根素能抑制二磷酸腺苷 (ADP)诱导和 5-ΗΤ(5-羟色胺)与 ADP联合诱导的人和动物的血小板聚集;另外,葛根素还能明显抑制由凝血酶诱导的血小板中 5-ΗΤ 的释放, 具有抗血栓形成作用。 7 降血糖的作用 葛根素能对抗肾上腺素的升血糖作用, 具有一定 的降血糖能力。 8 对体温的影响 葛根总黄酮对内毒素致体温升高具有转持久而明显的降温作用, 临床上常用于外感发热诸症。9 对记忆的影响 总黄酮和醇提物能提高大鼠大脑皮层和海马乙酰胆 碱含量, 并降低海马乙酰胆碱转移酶活性, 对抗东莨碱所效的大鼠记忆获得性障碍, 这说明, 葛根 具有一定的改善学习记忆的能力。 Efficacy of Pueraria Isoflavones: 1 Effect on Smooth Muscle Soybean aglycone in Pueraria has an anti-acetylcholine effect and can significantly contract smooth muscle, which is considered to be the main component of Pueraria lobata. 2 Effect on coronary circulation Pueraria decoction, alcohol extract, total flavonoids and puerarin have obvious effects of dilating coronary vessels, which can increase coronary blood flow and reduce vascular resistance. 3 Effects on myocardial infarction and arrhythmia Pueraria extract, soybean aglycone and puerarin have obvious arrhythmia effects induced by aconitine and barium chloride, and puerarin can also significantly shorten chloroform and adrenaline induction. During the arrhythmia of rabbits, puerarin can significantly reduce the extent of myocardial infarction and is considered to be a beta-adrenergic receptor blocker. 4 Effects on cardiac function and myocardial metabolism Pueraria total flavonoids and puerarin can slow heart rate, reduce total peripheral resistance of the heart, reduce myocardial oxygen consumption, and improve myocardial efficiency. Puerarin can also significantly reduce myocardial lactic acid caused by ischemia. Produce and improve the metabolism of infarcted myocardium. 5 Effects on blood pressure and peripheral blood vessels Pueraria radix ketone and puerarin can significantly reduce plasma renin activity and angiotensin, and blood pressure decreases. Puerarin has a significant improvement effect on microcirculatory disorders, mainly manifested by increased microvascular movement. Amplitude and increase local micro-blood flow; total flavonoids from Pueraria lobata have a significant effect on dilating cerebral blood vessels, improving brain microcirculation and peripheral circulation. It has been reported that puerarin can also improve the blockade of retinal vascular end units, thereby improving visual function. 6 inhibition of platelet aggregation puerarin can inhibit adenosine diphosphate (ADP) induction and 5-ΗΤ (5-hydroxytryptamine) combined with ADP induced platelet aggregation in humans and animals; in addition, puerarin can also significantly inhibit the induction of thrombin The release of 5-quinone in platelets has an antithrombotic effect. 7 The role of hypoglycemia Puerarin can counteract the agglutination of epinephrine and has a certain ability to lower blood sugar. 8 Effect on body temperature The total flavonoids of Radix Puerariae have a long-lasting and obvious cooling effect on the increase of body temperature caused by endotoxin. It is often used in external fever and fever. 9 Effects on memory Total flavonoids and alcohol extracts can increase acetylcholine content in rat cerebral cortex and hippocampus, and decrease hippocampal acetylcholine transferase activity against scopolamine-induced memory-acquired disorder in rats. Has a certain ability to improve learning and memory.
4、 香菇多糖  4, lentinan
香菇多糖为香菇提取物中的功效成分。 香菇又称香蕈、 椎耳、 香信、 冬菰、 厚菇、 花菇, 英文 名: Lentinat 香菇营养丰富, 味道鲜美, 被视为"菇中之王"。 其中含香菇多糖 (结构式如下) 有 十多种氨基酸, 其中有异亮氨酸、 赖氨酸、 苯丙氨酸、 蛋氨酸、 苏氨酸、 缬氨酸等 7种人体必需的 氨基酸, 还含有维生素 Bl、 B2、 PP及矿物盐。  Lentinus edodes polysaccharide is an effective ingredient in mushroom extract. Mushrooms are also known as citron, vertebral ear, sweet letter, winter glutinous rice, thick mushroom, flower mushroom, English Name: Lentinat Mushroom is rich in nutrients and delicious, and is regarded as the "king of mushrooms". It contains lentinan (structured as follows). There are more than ten kinds of amino acids, including 7 kinds of essential amino acids such as isoleucine, lysine, phenylalanine, methionine, threonine and proline. Bl, B2, PP and mineral salts.
香菇多糖是从优质香菇子实体中提取的有效活性成分,香菇的主要成分是多糖类和不饱和脂肪 酸, 还含有大量的可转变为维生素 D的麦角 醇和菌 醇, 经热水提取的香菇多糖可调节人体内 有免疫功能的 T细胞活性, 可降低甲基胆蒽诱发肿瘤的能力。 香菇对癌细胞有强烈的抑制作用, 对小白鼠肉瘤 180的抑制率为 97.5%, 对艾氏癌的抑制率为 80%。  Lentinus edodes polysaccharide is an effective active ingredient extracted from high-quality mushroom fruit body. The main components of shiitake mushroom are polysaccharides and unsaturated fatty acids, and also contain a large amount of ergosterol and mycohol which can be converted into vitamin D. It can regulate the immune function of T cells in the human body, which can reduce the ability of methylcholine to induce tumors. Mushrooms have a strong inhibitory effect on cancer cells, with an inhibition rate of 97.5% for mouse sarcoma 180 and 80% for Ehrlich cancer.
5、 枸杞子  5, scorpion
枸杞子自古就是滋补养人的上品, 有延衰抗老的功效, 所以又名"却老子"。 枸杞性甘、 平, 归 肝肾经, 具有滋补肝肾, 养肝明目的功效, 常与熟地、 菊花、 山药、 山萸肉等药同用。 枸杞子亦为 扶正固本, 生精补髓、 滋阴补肾、 益气安神、 强身健体、 延缓衰老之良药, 对慢性肝炎、 中心性视 网膜炎、 视神经萎縮等疗效显著; 对糖尿病、 肺结核等也有较好疗效; 对抗肿瘤、 保肝、 降压、 降 血糖以及老年人器官衰退的老化疾病都有很强的改善作用。作为滋补强壮剂治疗肾虚各症及肝肾疾 病疗效甚佳, 能显著提高人体中血浆睾酮素含量, 达到强身之功效。现代医学研究表明, 枸杞对体 外癌细胞有明显的抑制作用, 可用于防止癌细胞的扩散和增强人体的免疫功能.。 现代分析表明, 枸杞子所含之营 成分非常丰富, 每百克枸杞果中含粗蛋白 4.49克, 粗脂肪 2.33克, 碳水化合物 9.12克, 类胡萝卜素 96毫克, 硫胺素 0.053毫克, 核黄素 0.137毫克, 抗坏血酸 19.8毫克, 甜菜 碱 0.26毫克, 还含有丰富的钾、 钠、 钙、 镁、 铁、 铜、 锰、 锌等元素, 以及 22种氨基酸和多种维 生素。 其中的枸杞多糖功能因子具有十分重要的、 多方面的保健功能作用:  Since ancient times, Scorpion has been the top grade for nourishing and supporting people. It has the effect of prolonging the decline and resisting the old, so it is also known as "the old man." It has the functions of nourishing liver and kidney, nourishing liver and clearing the eye. It is often used together with rehmannia, chrysanthemum, yam, hawthorn and other medicines. Scorpion is also a good solution for strengthening the body, replenishing the marrow, nourishing yin and tonifying the kidney, replenishing qi and calming the nerves, strengthening the body, and delaying aging. It has a remarkable effect on chronic hepatitis, central retinitis, optic atrophy, etc.; for diabetes, tuberculosis, etc. It also has a good effect; it has a strong improvement effect on aging diseases such as anti-tumor, liver protection, blood pressure reduction, blood sugar lowering and organ decay in the elderly. As a nourishing and strong agent for the treatment of kidney deficiency and liver and kidney disease, it has a very good effect, which can significantly improve the plasma testosterone content in the human body and achieve the effect of strengthening the body. Modern medical research has shown that strontium has a significant inhibitory effect on extracellular cancer cells and can be used to prevent the spread of cancer cells and enhance the body's immune function. Modern analysis shows that the scorpion contains a very rich camp, containing 4.49 grams of crude protein per 100 grams of fruit, 2.33 grams of crude fat, 9.12 grams of carbohydrates, 96 mg of carotenoids, 0.053 mg of thiamine, nuclear yellow. 0.137 mg, ascorbic acid 19.8 mg, betaine 0.26 mg, rich in potassium, sodium, calcium, magnesium, iron, copper, manganese, zinc and other elements, as well as 22 amino acids and multivitamins. Among them, the 枸杞 polysaccharide functional factor has a very important and multi-faceted health function:
(1)免疫调节作用 枸杞多糖对小鼠非特异性免疫、 特异性免疫有非常显著的免疫调节作用, 能显 著地增强小鼠脾淋巴细胞增殖、迟发型变态反应、升高小鼠血清溶血素含量、小鼠腹腔巨噬鸡红细 胞功能、 小鼠碳廓清能力、 以及显著增强抗体生成的能力等。  (1) Immunomodulation 枸杞 Polysaccharide has a very significant immunomodulatory effect on non-specific immunity and specific immunity in mice, which can significantly enhance mouse spleen lymphocyte proliferation, delayed type hypersensitivity, and increase serum hemolysin content in mice. , mouse peritoneal macrophage chicken red blood cell function, mouse carbon clearance ability, and ability to significantly enhance antibody production.
(2)降血糖作用 枸杞多糖对实验性糖尿病有明显的降血糖作用, 有效率达 100%; 且对正常小鼠血 糖无影响。  (2) Hypoglycemic effect Lycium barbarum polysaccharide has obvious hypoglycemic effect on experimental diabetes, the effective rate is up to 100%; and it has no effect on blood sugar in normal mice.
(3)降血脂作用 枸杞多糖对实验性高脂血大鼠的血脂有明显影响, 可显著降低血清胆固醇、 甘油 三脂含量、 而对高密度脂蛋白有升高作用。 实验结果表明构把多糖有明显的调节血脂作用。 (4)延缓衰老作用 果蝇生存试验表明, 枸杞多糖可明显延长雌性及雄性果蝇的平均寿命及最高寿 命。 并有显著升高小鼠红细胞 SOD作用和明显降低 MDA的作用。 另外还有动物及临床实验结果 表明枸杞多糖能明显增强去胸腺小鼠的细胞免疫功能, 对小鼠性功能也有一定的恢复作用。 (3) hypolipidemic effect 枸杞 polysaccharide has a significant effect on the blood lipids of experimental hyperlipidemic rats, can significantly reduce serum cholesterol, triglyceride content, and has a higher effect on high-density lipoprotein. The experimental results show that the polysaccharide has obvious regulation of blood lipids. (4) Anti-aging effect Drosophila survival test showed that alfalfa polysaccharide can significantly prolong the average life expectancy and maximum life span of female and male fruit flies. It also significantly increased the role of SOD in mouse red blood cells and significantly reduced MDA. In addition, animal and clinical trial results show that lycium barbarum polysaccharide can significantly enhance the cellular immune function of dethymus mice, and also has a certain recovery effect on mouse sexual function.
(5)抗疲劳作用 构把多糖能提高实验小鼠的肌糖原、 肝糖原储备。 增加乳糖脱氨 的总活力、 加速 血尿素的清除和降低运动后的血乳酸水平, 能明显延长小鼠游泳时间。所以, 拘把多糖能增强机体 体力、 迅速消除运动后的疲劳。  (5) Anti-fatigue effect The polysaccharide can increase the muscle glycogen and liver glycogen reserve of experimental mice. Increasing the total activity of lactose deamination, accelerating the clearance of blood urea and lowering the blood lactate level after exercise can significantly prolong the swimming time of mice. Therefore, the polysaccharide can enhance the body's physical strength and quickly eliminate fatigue after exercise.
(6)其它作用 通过对天麻、 人参、 银杏、 枸杞提取物的试验表明: 枸杞提取物能显著延长动物缺 氧条件下及辐射条件下的存活时间。  (6) Other effects Tests on gastrodia elata, ginseng, ginkgo biloba, and alfalfa extracts showed that: alfalfa extract can significantly prolong the survival time of animals under hypoxic conditions and under irradiation conditions.
6、 鸡腿菇  6, chicken legs
鸡腿菇是鸡腿蘑的俗称, 因其形如鸡腿, 肉质肉味似鸡丝而得名, 是近年来人工开发的具有商 业潜力的珍稀菌品,被誉为"菌中新秀"。学名:毛头鬼伞。别名:鸡腿蘑、刺蘑菇 拉丁名: Copyinds comatus (MUII. Fr) Gray , 分类地位: 属于担子菌纲, 伞菌目, 鬼伞科, 鬼伞属。  Coprinus comatus is a common name for chicken leg mushrooms. It is named after chicken legs and meaty meat like chicken. It is a rare and rare product with commercial potential developed in recent years. It is known as "a rookie in bacteria". Scientific name: Maotou ghost umbrella. Alias: Coprinus comatus, thorn mushroom Latin name: Copyinds comatus (MUII. Fr) Gray, classification status: belonging to Basidiomycetes, Agaric, Coprinus, Coprinus.
鸡腿菇性平, 味甘滑, 具有清神益智, 益脾胃, 助消化, 增加食欲等功效。 鸡腿菇还含有抗癌 活性物质和治疗糖尿病的有效成分, 长期食用, 对降低血糖浓度, 治疗糖尿病有较好疗效, 特别对 治疗痔疮效果明显。  The chicken leg mushroom is flat, sweet and smooth, with clearing spirit, benefiting the spleen and stomach, helping digestion, increasing appetite and other effects. Coprinus comatus also contains anti-cancer active substances and active ingredients for the treatment of diabetes. Long-term consumption has a good effect on lowering blood sugar concentration and treating diabetes, especially for treating acne.
由于鸡腿菇集营养, 保健, 食疗于一身, 具有高蛋白, 低脂肪的优良特性。 且色, 香, 味形倶 佳。据《中国药用真菌图鉴》等书记载, 鸡腿蘑的热水提取物对小白鼠肉瘤 180和艾氏癌抑制率分 别为 100%和 90%。干鸡腿菇的具体营养成分为:总糖含量为 57.65 %,还原糖 53.54%,蛋白质 24.45 % , 粗脂肪 2.82%, 粗纤维 2.78 %, 灰分 10.8 %, 水分 0.2%。 由于鸡腿菇有一定的营养价值、 味 道鲜美, 受到消费者青睐, 因此鲜品较平菇价高 2— 3倍, 是一种珍稀食用菌。  Because of the nutrition, health care and therapeutic treatment, the chicken leg mushroom has the excellent characteristics of high protein and low fat. And color, fragrance, taste shape is good. According to the "Chinese Medicinal Fungi Picture Book" and other books, the hot water extract of Coprinus comatus has a inhibition rate of 100% and 90% for the sarcoma 180 and Ehrlich cancer. The specific nutrients of dried koji mushroom are: total sugar content is 57.65%, reducing sugar is 53.54%, protein is 24.45%, crude fat is 2.82%, crude fiber is 2.78%, ash is 10.8%, and moisture is 0.2%. Because of its certain nutritional value and delicious taste, Coprinus comatus is favored by consumers, so the fresh product is 2-3 times higher than the price of oyster mushrooms. It is a rare edible fungus.
7、 甜菊糖甙  7, stevioside
甜菊糖中的主要成分为甜菊糖甙, 作为一种新型甜味剂, 可以广泛应用于各类食品、饮料、 医 药、 日化工业。可以说凡是用糖产品几乎都可以用甜菊糖替代部分蔗糖或全部替代糖精等化学合成 甜味剂。 甜菊糖甙纯度 80%以上的甜菊糖为白色结晶或粉末, 吸湿性不大。 易溶于水、 乙醇, 与 蔗糖、 果糖、 葡萄糖、 麦芽糖等混合使用时, 不仅甜菊糖味更纯正, 且甜度可得到相乘效果。 该糖 耐热性差, 不易着光, 在 pH值 3〜10范围内十分稳定, 易存放。 溶液稳定性好, 在一般饮料食品 的 pH范围内, 进行加热处理仍很稳定。 甜菊糖在含有蔗糖的有机酸溶液中存放半年变化不大; 在 酸碱类介质中不分解可防止发酵, 变色和沉淀等; 并可降低粘稠度, 抑制细菌生长和延长产品保质 期。它与柠檬酸、苹果酸、酒石酸、乳酸, 有杜酸、氨基酸等使用时, 对甜菊糖的后味有消杀作用, 故与上述物质混合使用可起到矫味作用, 提高甜菊糖甜味质量。 The main ingredient in stevioside is stevioside, which is widely used in various foods, beverages, medicines, and the chemical industry as a new type of sweetener. It can be said that almost all sugar products can be replaced with stevia to replace some sucrose or all of the chemical sweeteners such as saccharin. The stevioside having a purity of 80% or more of stevioside is white crystal or powder, and has little hygroscopicity. Soluble in water, ethanol, and mixed with sucrose, fructose, glucose, maltose, etc., not only the stevia flavor is more pure, but the sweetness can be multiplied. The sugar has poor heat resistance, is not easy to be lighted, and is very stable in the pH range of 3 to 10, and is easy to store. The stability of the solution is good, and the heat treatment is still stable in the pH range of the general beverage food. Stevioside has little change in semi-annual storage in sucrose-containing organic acid solution; it does not decompose in acid-base medium to prevent fermentation, discoloration and precipitation; it can reduce viscosity, inhibit bacterial growth and prolong product shelf life. When it is used with citric acid, malic acid, tartaric acid, lactic acid, and acid, amino acid, it has a killing effect on the aftertaste of stevioside. Therefore, in combination with the above substances, it can play a flavoring effect and improve the sweetness quality of stevia.
功效特点 1、安全性高。甜菊糖原产地(南美巴拉圭、马西等地)的居民食用已有几百年历史, 至今未发现有任何毒害。 2、 低热值。 用于制做低热量食品、 饮料, 非常适用于糖尿病、 肥胖病、 动脉硬化患者食用。  Efficacy characteristics 1, high security. Residents of stevioside origin (South America, Paraguay, Masi, etc.) have been eating for hundreds of years and have not found any poison. 2. Low calorific value. It is used to make low-calorie foods and beverages, and is very suitable for patients with diabetes, obesity, and arteriosclerosis.
中医经络说认为, 随着现代生活水平升高, 生活节奏的加快, 吸烟、 大量饮酒、 高热量饮食等 不良的生活方式, 以及压抑、 紧张、 焦虑等社会心理因素均会引起体内代谢失衡和机体神经 -内分 泌-免疫网络紊乱, 从而导致高血压、 高血脂、 糖尿病等疾病发生。 糖尿病周围神经病变是典型的 由脉络病变引起的气络病变病理过程。络中气血阻滞不通是发病的关键, 并贯穿始终。糖尿病并发 症存在血脉瘀滞的病机,瘀郁热瘀互相胶结。因此本发明的产品采用北虫草、千佛菌、葛根异黄酮、 枸杞子的降血脂、 降血糖的功效, 并有防止动脉硬化, 改善脂肪代谢的作用, 使血脉通畅, 清理和 防止瘀滞, 达到预防和控制糖尿病的作用, 同时预防减少心血管并发症的发生; 利用北虫草、千佛 菌、 香菇多糖的提高免疫力的功效, 使糖尿病人提高自身的免疫力, 减少并发症的发生; 枸杞子是 滋补上品, 结合北虫草可以增强由于糖尿病人肾虚带来的体力不支现象, 提高抗疲劳能力, 提高患 者的运动能力, 使气络通脉, 枸杞子还有保肝, 对眼疾的显著疗效, 防止眼病并发症的发生; 结合 采用高蛋白、 低热量的香菇、 鸡腿菇作为营养成分, 使其加强运动的同时, 得到合理的营养补充, 鸡腿菇还能调整脾胃,助消化,减少积食。因此本发明选用了上述几种药食同源的食品组合,使气、 血脉通畅, 不仅可以很好的增强机体免疫力, 降低血糖, 同时对糖尿病的肾病、 神经病变、 消化道 疾病、 口腔疾病、 阳痿、 皮肤和关节疾病以及下肢动脉硬化闭塞症等并发症都有良好的改善作用, 对初期、 轻症病人能较好的控制糖尿病并发症的发生。  The traditional Chinese medicine meridians said that with the rise of modern living standards, the pace of life is accelerating, smoking, heavy drinking, high-calorie diets and other unhealthy lifestyles, as well as social and psychological factors such as depression, tension, anxiety, etc., can cause metabolic imbalance and body Neuro-endocrine-immune network disorders lead to diseases such as hypertension, hyperlipidemia, and diabetes. Diabetic peripheral neuropathy is a typical pathological process of gastro-intestinal disease caused by choroidal lesions. The qi and blood block in the collaterals is the key to the onset, and it runs through. Diabetes complicates the pathogenesis of blood stasis, and the enthusiasm and enthusiasm cement each other. Therefore, the product of the invention adopts the effects of Cordyceps militaris, Thousand Buddha, Puerarin isoflavones, medlar to lower blood fat and lower blood sugar, and has the functions of preventing arteriosclerosis, improving fat metabolism, smoothing blood circulation, cleaning and preventing stasis, To prevent and control the role of diabetes, and to prevent the occurrence of cardiovascular complications; the use of Cordyceps militaris, Thousand Buddha, lentinan to improve the immune system, so that people with diabetes improve their immunity, reduce the occurrence of complications; The medlar is a nourishing top grade. Combining Cordyceps militaris can enhance the physical disability caused by kidney deficiency in diabetic patients, improve the anti-fatigue ability, improve the patient's exercise capacity, make the qi and tongs, the scorpion also protects the liver, and the eye disease is remarkable. Efficacy, prevention of eye disease complications; combined with high protein, low calorie mushrooms, Coprinus comatus as a nutrient, to enhance exercise, while getting a reasonable nutritional supplement, Coprinus comatus can also adjust the spleen and stomach, help digestion, reduce food accumulation . Therefore, the present invention selects the food combinations of the above-mentioned several medicines and foods to make the gas and blood vessels smooth, not only can enhance the body immunity, lower blood sugar, and at the same time, diabetic nephropathy, neuropathy, digestive tract diseases, oral diseases. Complications such as impotence, skin and joint diseases, and lower extremity arteriosclerosis obliterans have a good effect. Early and mild patients can better control the occurrence of diabetic complications.
为了改善上述组合物的口感, 本发明添加有甜菊糖甙, 一来作为甜味剂, 不会提高患者血糖, 同时与其它提取物配合使用时, 起到了矫味作用, 同时可以适当延长产品的保质期。  In order to improve the mouthfeel of the above composition, the present invention is added with stevioside, and as a sweetener, it does not improve the blood sugar of the patient, and at the same time, when used in combination with other extracts, it has a flavoring effect and can appropriately extend the product. Shelf life.
本发明主要用于口服给药, 可将其制成常规的固体制剂, 包括片剂、 胶囊剂、 颗粒剂、 丸剂和 口服溶液剂等。片剂系指药物与适宜的辅料混匀压制而成的圆片状或异形片状的固体制剂;片剂以 口服普通片为主, 另有含片、 舌下片、 口腔贴片、 咀嚼片、 分散片、 可溶片、 泡腾片、 缓释片、 控 释片与肠溶片等。胶囊剂系指药物或加有辅料充填于空心胶囊或密封于软质囊材中的固体制剂;胶 囊剂依据其溶解与释放特性, 可分为硬胶囊 (通称为胶囊)、 软胶囊 (胶丸)、 缓释胶囊、 控释胶囊和 肠溶胶囊。颗粒剂系指药物与适宜的辅料制成具有一定粒度的干燥颗粒状制剂;颗粒剂可分为可溶 颗粒 (通称为颗粒)、 混悬颗粒、 泡腾颗粒、 肠溶颗粒、 缓释颗粒和控释颗粒等。 丸剂系指药物与适 宜的辅料均匀混合, 以适当方法制成的球状或类球状固体制剂; 丸剂包括滴丸、 糖丸、 小丸等。 口 服溶液剂系指药物溶解于适宜溶剂中制成供口服的澄清液体制剂。 The present invention is mainly used for oral administration, and can be formulated into conventional solid preparations including tablets, capsules, granules, pills, oral solutions, and the like. Tablet refers to a solid preparation of tablets or shaped tablets which are mixed with a suitable excipient and a suitable excipient; the tablets are mainly oral tablets, and include tablets, sublingual tablets, oral patches, and chewable tablets. , dispersible tablets, soluble tablets, effervescent tablets, sustained release tablets, controlled release tablets and enteric coated tablets. Capsule refers to a solid preparation filled with a drug or an auxiliary material filled in a hollow capsule or sealed in a soft capsule; the capsule can be classified into a hard capsule (commonly known as a capsule) and a soft capsule (a capsule according to its dissolution and release characteristics). ), sustained release capsules, controlled release capsules and enteric capsules. Granules refer to pharmaceuticals and suitable excipients to form dry granular preparations having a certain particle size; granules can be divided into soluble particles (commonly known as granules), suspended granules, effervescent granules, enteric granules, sustained release granules and Controlled release granules, etc. Pill means a spherical or spheroidal solid preparation which is uniformly mixed with a suitable excipient and is prepared by a suitable method; the pill includes a dropping pill, a sugar pill, a pellet, and the like. mouth By solution is meant a clear liquid preparation in which the drug is dissolved in a suitable solvent for oral administration.
本发明的制剂可采用现有制药领域中的常规方法生产,需要的时候可以添加各种药学上可接受 的载体。 所述的载体包括药学领域常规的渗透压调节剂、 pH值调节剂、 增溶剂、 抗氧剂、 抑菌剂、 乳化剂、 助悬剂、 填充剂、 粘合剂、 崩解剂、 润滑剂等, 属本发明中辅料的一部分。 本发明在制成 口服制剂时, 可以加入适宜的填充剂、 粘合剂、 崩解剂、 润滑剂等辅料。 填充剂包括淀粉、 糖粉、 磷酸钙、 硫酸钙二水物、 糊精、 微晶纤维素、 乳糖、 预胶化淀粉、 甘露醇等; 粘合剂包括羧甲基纤 维素钠、 PVP-K30、 羟丙基纤维素、 淀粉浆、 甲基纤维素、 乙基纤维素、 羟丙甲纤维素、 胶化淀粉 等; 崩解剂包括干淀粉、 交联聚维酮、 交联羧甲基纤维素钠、 羧甲基淀粉钠、 低取代羟丙基纤维素 等; 润滑剂包括硬脂酸镁、 滑石粉、 十二烷基硫酸钠、 微粉硅胶等。  The preparation of the present invention can be produced by a conventional method in the field of the prior art, and various pharmaceutically acceptable carriers can be added as needed. The carrier includes a conventional osmotic pressure adjusting agent, a pH adjusting agent, a solubilizing agent, an antioxidant, a bacteriostatic agent, an emulsifier, a suspending agent, a filler, a binder, a disintegrating agent, and a lubricant in the pharmaceutical field. Etc., is part of the excipients of the present invention. In the preparation of the oral preparation of the present invention, a suitable filler, a binder, a disintegrant, a lubricant and the like may be added. Fillers include starch, powdered sugar, calcium phosphate, calcium sulfate dihydrate, dextrin, microcrystalline cellulose, lactose, pregelatinized starch, mannitol, etc.; binders include sodium carboxymethylcellulose, PVP-K30 , hydroxypropyl cellulose, starch syrup, methyl cellulose, ethyl cellulose, hypromellose, gelatinized starch, etc.; disintegrants include dry starch, crospovidone, crosslinked carboxymethyl fiber Sodium, sodium carboxymethyl starch, low-substituted hydroxypropyl cellulose, etc.; lubricants include magnesium stearate, talc, sodium lauryl sulfate, micronized silica gel, and the like.
实施例中进行的中药活性成分水提取物的操作以及加入的赋形剂的具体含量,均是本领域的常 规技术, 是所属领域的技术人员容易实现的, 不存在公开不充分的问题。实施例的目的是说明本发 明的组合物可以制成常规剂型, 而不是用于限制其保护范围或影响其公开充分。  The operation of the aqueous extract of the active ingredient of the traditional Chinese medicine carried out in the examples and the specific content of the added excipients are all conventional techniques in the art, and are easily realized by those skilled in the art, and there is no problem of insufficient disclosure. The purpose of the examples is to demonstrate that the compositions of the present invention can be formulated into conventional dosage forms, and are not intended to limit the scope of their protection or to affect their disclosure.
本发明的产品, 采用北虫草提取物, 千佛菌提取物, 香菇多糖, 葛根异黄酮, 枸杞提取物和鸡 腿菇提取物作为其有效成分, 使亚健康人群、 免疫力低下人群和糖尿病患者气、血脉通畅, 在达到 降血糖的同时控制糖尿病并发症的发生, 增强机体免疫力, 是一款一举多得的功能性保健食品。 具体实施方式  The product of the invention adopts Cordyceps militaris extract, Thousand Buddha extract, Lentinus edodes polysaccharide, Pueraria lobata extract, Lycium barbarum extract and Coprinus comatus extract as active ingredients thereof, so that sub-healthy people, immunocompromised people and diabetic patients It is a functional health food that can control the occurrence of diabetic complications and enhance the body's immunity while achieving blood sugar lowering. detailed description
原料: Raw materials:
北虫草提取物, 千佛菌提取物, 枸杞提取物和鸡腿菇提取物以水作为溶剂提取, 采用中药常规 水提方法提取得到。  Cordyceps militaris extract, Thousand Buddha extract, medlar extract and Coprinus comatus extract are extracted with water as a solvent, and extracted by conventional water extraction method of traditional Chinese medicine.
香菇多糖, 葛根异黄酮, 甜菊糖甙是市售产品。  Lentinus edodes polysaccharide, puerarin isoflavone, stevioside is a commercially available product.
实施例 1 Example 1
北虫草提取物 60g, 千佛菌提取物 400g, 香菇多糖 250g, 葛根异黄酮 70g, 枸杞提取物 100g、 鸡腿菇提取物 120g, 按常规方法制成胶囊。  Cordyceps militaris extract 60g, Thousand Buddha extract 400g, lentinan 250g, Pueraria isoflavone 70g, medlar extract 100g, Coprinus comatus extract 120g, capsules were prepared according to conventional methods.
实施例 2 Example 2
北虫草提取物 50g, 千佛菌提取物 500g, 香菇多糖 200g, 葛根异黄酮 100g, 枸杞提取物 70g、 鸡腿菇提取物 150g, 加入适量甜菊糖甙调味混匀, 按常规方法制成颗粒剂。  Cordyceps militaris extract 50g, Thousand Buddha extract 500g, Lentinus edodes polysaccharide 200g, Pueraria lobata 100g, Lycium barbarum extract 70g, Coprinus comatus extract 150g, add appropriate amount of stevioside, mix and mix, and prepare granules according to the conventional method.
实施例 3 Example 3
北虫草提取物 100g, 千佛菌提取物 350g, 香菇多糖 300g, 葛根异黄酮 50g,枸杞提取物 150g、 鸡腿菇提取物 80g, 混合溶于 lOOKg水中, 加入适量稳定剂, 甜菊糖甙调味即可。 实施例 4 Cordyceps sinensis extract 100g, Thousand Buddha extract 350g, lentinan 300g, Pueraria isoflavone 50g, medlar extract 150g, Coprinus comatus extract 80g, mixed in lOOKg water, add appropriate amount of stabilizer, stevioside can be seasoned . Example 4
北虫草提取物 80g, 千佛菌提取物 450g, 香菇多糖 200g, 葛根异黄酮 80g, 枸杞提取物 80g、 鸡腿菇提取物 200g, 混合溶于 lOOKg水中, 加入适量稳定剂, 甜菊糖甙调味即可。  Cordyceps sinensis extract 80g, Thousand Buddha extract 450g, Lentinus edodes 200g, Puerariae isoflavone 80g, Lycium barbarum extract 80g, Coprinus comatus extract 200g, mixed in lOOKg water, add appropriate amount of stabilizer, stevioside can be seasoned .
实验例: 本保健食品的降血糖功能动物实验结果: (《保健食品检验与评价技术规范》中华人民共和 国卫生部 2003版) 1. 1材料 Experimental example: Experimental results of hypoglycemic functional animals in the health food: ("Technical Specifications for Health Food Inspection and Evaluation", Ministry of Health, Chinese People's Republic of China, 2003 Edition) 1. 1 Materials
1. 1. 1试物: 本实施例 1制备的保健食品, 成人推荐量有效成分重量为每日 720mg/d, 按成人 60kg体重计, 即 12mg/ (kg体重)。  1. 1. 1 test substance: The health food prepared in the first embodiment has an active ingredient weight of 720 mg/d per day, which is 12 mg/kg body weight, based on 60 kg body weight of an adult.
1. 1. 2试验动物: 选用体重为 180g ± 200g的成年大鼠, 雄性, 100只, 购自湖北省实验动物研 究中心, 合格证号为医动字第 2009-0810号。  1. 1. 2 Test animals: Adult rats weighing 180g ± 200g, male, 100 were purchased from Hubei Experimental Animal Research Center, and the certificate number is No. 2009-0810.
1. 1. 3剂量选择: 试验设三个剂量组: 10倍人体摄入量低剂量组、 20倍人体摄入量中剂量组、 30倍人体摄入量高剂量组和高血糖模型对照组。小鼠灌胃体积为 0.2ml/10g体重。受试物给予时间  1. 1. 3 dose selection: The experiment consists of three dose groups: 10 times human intake low dose group, 20 times human intake medium dose group, 30 times human intake high dose group and high blood glucose model control group . The oral volume of the mice was 0.2 ml/10 g body weight. Test subject time
1. 1. 4主要仪器与试剂: 血糖仪、 全自动生化仪、 721— B型分光光度计; 四氧嘧啶, 用前新 鲜配制。 1. 1. 4 main instruments and reagents: blood glucose meter, automatic biochemical analyzer, 721-B spectrophotometer; alloxan, fresh preparation before use.
1.2实验方法 1.2 Experimental methods
1.2.1糖耐量试验 1.2.1 Glucose tolerance test
( 1 ) 高血糖模型动物  (1) Hyperglycemic model animals
①原理四氧嘧啶是一种胰岛 细胞毒剂, 可选择性地损伤多种动物的胰岛 细胞, 造成胰岛素分 泌低下, 引起实验性糖尿病。  1 Principle Alloxan is an islet cell cytotoxic agent that selectively damages islet cells of various animals, resulting in low insulin secretion and causing experimental diabetes.
②造模动物禁食 24h后, 给予四氧嘧啶造型。 给予方法为: 小鼠静脉注射四氧嘧啶 35〜50mg/kg 体重、大鼠静脉注射四氧嘧啶 50〜80mg/kg体重。 5〜7d后禁食 3〜5h,测定血糖,血糖值达到 10〜 25mmol/L时, 即为造模成功。  2 After the model animals were fasted for 24 hours, the alloxan was given. The administration method is as follows: the mice are intravenously injected with alloxan 35 to 50 mg/kg body weight, and the rats are intravenously injected with alloxan 50 to 80 mg/kg body weight. After 5~7d, fasting for 3~5h, measuring blood sugar, blood glucose value reached 10~25mmol/L, which is successful modeling.
( 2 ) 糖耐量试验测定 高血糖模型动物禁食 3〜5h, 剂量组给予不同浓度受试物, 模型对照组给予同体积溶剂。 15〜 20min后, 经口给予葡萄糖 2. 0g/kg, 测定给予葡萄糖后 0、 0. 5h、 2h的血糖值, 观察模型对照组 与受试物组给葡萄糖后, 各时间点血糖曲线下面积的变化。 血糖曲线下面积=丄 (Α00·5 ) X 0. 5+ (A2+A0 X I. 5 = 0. 25 (A。+4A。.5+ 3A2) (2) Determination of glucose tolerance test The hyperglycemic model animals were fasted for 3 to 5 hours. The dose group was given different concentrations of the test substance, and the model control group was given the same volume of solvent. After 15 to 20 minutes, glucose was 2.0 g/kg orally, and blood glucose levels of 0, 0.5 h, and 2 h after glucose administration were measured, and the area under the blood glucose curve at each time point was observed after the model control group and the test group were given glucose. The change. Area under the blood glucose curve = 丄(Α 00 · 5 ) X 0. 5+ (A2+A0 X I. 5 = 0. 25 (A.+4A.. 5 + 3A 2 )
2 注意事项:为了使试验动物糖代谢功能状态尽量保持一致,也为了准确地按体重计算受试物的用量, 试验前动物应严格禁食 (不禁水), 试验前后禁食条件应一致, 鼠类在禁食的同时应更换衬垫物。 1.3血糖测定方法 (葡萄糖氧化酶法)  2 Note: In order to make the test animal's function of glucose metabolism as consistent as possible, and in order to accurately calculate the dosage of the test substance by weight, the animals should be strictly fasted before the test (cannot be prohibited), the fasting conditions should be consistent before and after the test, the rats Classes should be replaced with padding while fasting. 1.3 blood glucose determination method (glucose oxidase method)
1.3.1 原理葡萄糖氧化酶是一种需氧脱氢酶, 能催化葡萄糖生成葡萄糖酸和过氧化氢。 后者在 过氧化物酶作用下放出氧, 继而使 4-氨基安替比林与酚氧化縮合, 生成红色醌类化合物, 可在波 长 505nm下比色测定。 1.3.1 Principle Glucose oxidase is an aerobic dehydrogenase that catalyzes the production of glucose by gluconic acid and hydrogen peroxide. The latter releases oxygen under the action of peroxidase, which in turn oxidatively condenses 4-aminoantipyrine with a phenol to form a red terpenoid which can be measured by colorimetric at a wavelength of 505 nm.
1.3.2试剂配制 1.3.2 reagent preparation
① 0.2mol/L磷酸盐缓冲液(pH7.0): 0.2mol/L Na2HP04 61mL与 0.2mol/L KH2P04 39mL混合 即可。 1 0.2 mol/L phosphate buffer (pH 7.0): 0.2 mol/L Na 2 HP0 4 61 mL may be mixed with 0.2 mol/L KH 2 P0 4 39 mL.
② 酶度剂: 葡萄糖氧化酶 400U, 过氧化物酶 0.6mg, 4-氨基安替比林 10mg, 叠氮钠 lOOmg, 加磷酸盐缓冲液至 lOOmL, pH值调至 7。 冰箱存放至少可稳定 2个月。  2 Enzymes: glucose oxidase 400U, peroxidase 0.6mg, 4-aminoantipyrine 10mg, sodium azide lOOmg, phosphate buffer to lOOmL, pH adjusted to 7. The refrigerator can be stored for at least 2 months.
③ 酚试剂: 将 lOOmg酚溶于 lOOmL蒸馏水中。  3 Phenol reagent: Dissolve 100 mg of phenol in 100 mL of distilled water.
④ 酶混合试剂: 取等量酶试剂和酚试剂混合。 在冰箱中可存放 1个月。  4 Enzyme mixing reagent: Mix the same amount of enzyme reagent and phenol reagent. It can be stored in the refrigerator for 1 month.
⑤ 葡萄糖标准液储备液: 无水 D-葡萄糖 (AR) 在烘箱中 80°C烘 4h, 冷却后, 存放于干燥器 中至恒重。 精确称取 2g, 用 0.25%苯甲酸溶液溶解后移入 lOOmL容量瓶中, 再用苯甲酸溶液稀释 至 100mL。  5 Glucose standard stock solution: Anhydrous D-glucose (AR) is baked in an oven at 80 ° C for 4 h, cooled and stored in a desiccator to constant weight. Accurately weigh 2g, dissolve it in 0.25% benzoic acid solution, transfer it to a lOOmL volumetric flask, and dilute to 100mL with benzoic acid solution.
⑥ 使用液: 在 lOOmL容量瓶中准确加入储备液 5mL, 用 0.25%苯甲酸溶液稀释至 lOOmL,即 可 lmg/mL使用液。 6 Use liquid: Accurately add 5mL of stock solution in lOOmL volumetric flask, dilute to lOOmL with 0.25% benzoic acid solution, that is, use lmg/mL.
⑦ 蛋白沉淀剂:溶解磷酸氢二钠 10g、钨酸钠 10g、氯化钠 9g于 800mL蒸馏水中,加入 lmol/L 盐酸 125mL, 并用蒸馏水稀释至 1 000mL。 1.3.3操作步骤 7 Protein precipitant: Dissolve 10 g of disodium hydrogen phosphate, 10 g of sodium tungstate, 9 g of sodium chloride in 800 mL of distilled water, add 125 mL of 1 mol/L hydrochloric acid, and dilute to 1000 mL with distilled water. 1.3.3 Operation steps
取蛋白沉淀剂 lmL, 加入血浆(血清) 50uL,, 混匀。 室温放置 7min后, 离心, 取上清液(无 血滤液) 测定。 葡萄糖标准使用液也进行同样处理。 按表 1的程序操作。 表 1 葡萄糖氧化酶法测定血糖的操作步骤 I mL  Take 1 mL of protein precipitant, add 50 μL of plasma (serum), and mix. After standing at room temperature for 7 min, centrifuge and take the supernatant (no blood filtrate) for determination. The same treatment was also carried out for the glucose standard use solution. Follow the procedure in Table 1. Table 1 Operation steps of glucose oxidase method for measuring blood glucose I mL
Figure imgf000012_0001
Figure imgf000012_0001
混匀后, 37°C水浴保温 15min,用空白管调零点, 在波长 505nm处比色 1.3.3.4结果计算  After mixing, heat in a 37 ° C water bath for 15 min, adjust the zero point with a blank tube, and calculate the colorimetric value at the wavelength of 505 nm.
18 式中, A A2分别代表测定管、 标准管的吸光度值。 本保健食品的降血糖功能动物实验结果见表 2: In the formula 18, AA 2 represents the absorbance values of the measuring tube and the standard tube, respectively. The experimental results of the hypoglycemic functional animals of the health food are shown in Table 2:
表 2 本保健食品对高血糖模型小鼠糖耐量的影响 (¥士 SD) 组别 动物只数 给葡萄糖后血糖水平 (mmol/L) 葡萄糖曲线  Table 2 Effect of the health food on glucose tolerance in hyperglycemic model mice (¥士 SD) Group Animals only Glucose levels after glucose (mmol/L) Glucose curve
oh 0.5h 2h 下面积  Oh 0.5h 2h area
高血糖模型 24.4 ±5.6 41.4 ±5.8 28.2 ±7.0 68± 10 Hyperglycemia model 24.4 ±5.6 41.4 ±5.8 28.2 ±7.0 68± 10
低剂量组 20.7±7.1 34.4 ±6.2 23.1 ±8.2 60士 12  Low dose group 20.7±7.1 34.4 ±6.2 23.1 ±8.2 60士 12
中剂量组 18.8 ±7.3 32.8 ±6.3* 21.7±7.3 53 士 12  Medium dose group 18.8 ±7.3 32.8 ±6.3* 21.7±7.3 53 ± 12
高剂量组 19.0±5.1 32.0 ±5.0* 20.2 ±6.4 52士 10  High dose group 19.0±5.1 32.0 ±5.0* 20.2 ±6.4 52士 10
*与空白对照组相比有较显著性差异 (P<0.01) 经口给予小鼠不同剂量的本保健食品 31d, 与高血糖模型对照组比较, 中剂量组能降低给葡萄 糖后 0.5血糖值(P<0.01)、 降低给葡萄糖后 0〜2h血糖曲线下面积(P<0.05); 高剂量组能降低 给葡萄糖后 0. 5h血糖值 (P<0. 05)、 降低给后 0〜2h血糖曲线下面积 (P<0. 05 ); 且受试物对小 鼠体重和正常小鼠空腹血糖均无不良影响。 根据《保健食品检验与评价技术规范》(2003版)对降 血糖功能保健食品的判定标准可判定本保健食品降血糖功能动物实验结果阳性。 * Compared with the blank control group, there was a significant difference (P<0.01). The oral administration of different doses of the health food for 31 days was compared with the hyperglycemic model control group, and the middle dose group was able to reduce the blood glucose level after glucose administration ( P<0.01), reduce the area under the blood glucose curve of 0~2h after glucose administration (P<0.05); high dose group can reduce After glucose administration, the blood glucose level was 0.5 h (P < 0.05), and the area under the blood glucose curve after 0 to 2 h was decreased (P <0.05); and the test article had no effect on the body weight of mice and fasting blood glucose in normal mice. Bad effects. According to the "Technical Specification for Health Food Inspection and Evaluation" (2003 edition), the criteria for determining the blood sugar lowering function health food can be judged as positive for the blood sugar lowering function of the health food.
实验例 2 : 本保健食品的降血糖功能人体实验结果: Experimental Example 2: The blood sugar lowering function of the health food product results in human experiment:
病例选择与临床观察本发明保健食品的降血糖功能人体实验, 经 30例系统临床观察, 并选择 病史、病情、年龄、 性别及原治疗方法相当的糖尿病患者 7例为对照组。 从住院及内分泌专科门诊 选择病例, 按卫生部 1980年制定的糖尿病诊断标准, 确认为成年糖尿病患者的, 在口服降糖药及 胰岛素治疗的基础上, 空腹血糖 7. 2mm0l/L者为观察对象, 其中男 15例, 女 15例, 年龄 40〜55 岁。 病程半年〜 15年。 Case selection and clinical observation The human body experiment of hypoglycemic function of the health food of the present invention was carried out in 30 cases systematically, and 7 cases of diabetes patients with the same medical history, condition, age, sex and original treatment method were selected as the control group. The selected cases from the inpatient and endocrinology clinics were confirmed to be adult diabetic patients according to the diagnostic criteria for diabetes established by the Ministry of Health in 1980. On the basis of oral hypoglycemic agents and insulin therapy, fasting blood glucose was 7. 2mm 0 l/L. Observed subjects, including 15 males and 15 females, aged 40 to 55 years old. The course of disease is half a year ~ 15 years.
试验组: 在原治疗基础上, 停用降糖药, 服本发明实施例 4制备的保健食品, 成人推荐量有效 成分每日 720mg/d o 按成人 60kg体重计, 即 12mg/ (kg体重)。  Test group: On the basis of the original treatment, the hypoglycemic agent was deactivated, and the health food prepared in Example 4 of the present invention was used. The recommended amount of the active ingredient per adult was 720 mg/d o per day, which is 12 mg/kg body weight.
对照组: 按常规降糖治疗, 其中降糖药物、 品种用法用量与试验相匹配。  Control group: According to the conventional hypoglycemic treatment, the dosages of the hypoglycemic drugs and the varieties were matched with the test.
采用相同方法定期检查空腹血糖, 观察期三个月, 一个月为一疗程。 共三个疗程。  The fasting blood glucose was regularly checked by the same method, and the observation period was three months, and one month was a course of treatment. A total of three courses.
实验结果如表 3 The experimental results are shown in Table 3.
表 3 服用本发明保健食品前后血糖变化  Table 3 Changes in blood glucose before and after taking the health food of the present invention
Figure imgf000013_0001
Figure imgf000013_0001
从表 3可以看出, 两组试验前空腹血糖浓度和降糖药物用量基本相似, P〉0. 05, 试验组服用 本发明保健食品后血糖下降, 降糖药用量却比原来减少 1/3〜1/2。  It can be seen from Table 3 that the fasting blood glucose concentration and the amount of hypoglycemic drugs before the two groups were basically similar, P>0.05, the blood glucose of the experimental group was decreased after taking the health food of the present invention, and the amount of hypoglycemic medicine was reduced by 1/ 3 to 1/2.
根据《保健食品检验与评价技术规范》(2003版)对降血糖功能保健食品的判定标准, 可判定 本保健食品人体实验结果表明具有明显的降血糖功能。  According to the "Technical Specification for Health Food Inspection and Evaluation" (2003 edition), the criteria for determining the blood sugar lowering function health food can be judged that the human body experiment results of the health food product indicate that the blood sugar lowering function is obvious.
实验例 3: 我们还测定了试验糖尿病人, 服用本发明实施例 4制备的保健食品前后机体免疫功能的 有关数据, 并与正常人作对照, 结果见表 4 Experimental Example 3: We also measured the immune function of the test diabetic patients before and after taking the health food prepared in Example 4 of the present invention. Relevant data, and compared with normal people, the results are shown in Table 4.
表 4 T细胞亚群测定结果 Table 4 T cell subset determination results
Figure imgf000014_0001
τ细胞亚群的检测方法是采用常规的碱性磷酶抗碱性磷酸酶法。测定数据表明, 糖尿病患者在 服用本发明药物之前 okT3显著地高于正常人, okT4/okT3比值明显降低, 服用本发明保健食品之后, 二者均大致恢复正常, 表明本发明保健食品有增强机体免疫功能。
Figure imgf000014_0001
The method for detecting the tau cell subset is to use a conventional alkaline phosphatase anti-alkaline phosphatase method. The measurement data showed that the okT 3 was significantly higher than that of the normal person before taking the drug of the present invention, and the okT 4 /okT 3 ratio was significantly decreased. After taking the health food of the present invention, both of them substantially returned to normal, indicating that the health food of the present invention has Enhance the body's immune function.
实验例 4 Experimental example 4
本保健产品的增强免疫力功能学试验标准,依据卫生部《保健食品检验与评价技术规范》 ( 2003 ) 年版进行, 试验结果如下:  The functional test standards for enhanced immunity of this health care product are based on the "Technical Specifications for Health Food Inspection and Evaluation" (2003) of the Ministry of Health. The test results are as follows:
1.材料与方法 1. Materials and methods
1.1试验材料: 本发明实施例 3制得的本发明产品; 成人推荐量每日 2g/d。 按成人 60kg体重计, 即 33mg / ( kg *体重)。  1.1 Test material: The product of the invention obtained in Example 3 of the present invention; the recommended amount for adults is 2 g/d per day. According to the adult 60kg body weight, that is, 33mg / (kg * body weight).
1.2试验动物: 清洁级 BALB / c小鼠, 雄性, 200只, 18〜22g,购自湖北省实验动物研究中心, 合 格证号为医动字第 2006— 0812号。  1.2 Test animals: Clean grade BALB / c mice, male, 200, 18~22g, purchased from Hubei Experimental Animal Research Center, and the syndrome number is No. 2006-0812.
1.3剂量选择: 试验设三个剂量组: 10倍人体摄入量 [0.33g/ (kg *体重)] 组、 20倍人体摄入量  1.3 Dose selection: The experiment consists of three dose groups: 10 times human intake [0.33g / (kg * weight)] group, 20 times human intake
[0.67g/ (kg *体重)] 组、 30倍人体摄入量 [ l .OOg/ (kg *体重)] 组和对照组。 小鼠灌胃体积为 0.2ml / 10g ·体重。  [0.67g / (kg * body weight)] group, 30 times human intake [l.OOg / (kg * body weight)] group and control group. The volume of the mice was 0.2 ml / 10 g · body weight.
1.4主要仪器与试剂: 5mm直径打孔器、 显微镜、 微量血凝试验板、 离心机、 酶标仪、 96孔培养 板、 5%C02培养箱、 200目筛网、 注射用墨汁、 刀豆蛋白 A ( ConA)、 MTT、 DNFB、 丙酮、 麻油、 脱毛剂、 SPBS、生理盐水、鸡红细胞、 甲醇、 Giemsa染液、 YAC— 1细胞、 Hanks液(pH7.2〜7.4)、 RPMI 1640完全培养液、 乳酸锂、 碘硝基氯化四氮唑(INT)、 吩嗪二甲酯硫酸盐(PMS)、 NAD、 Tris-HCI缓冲液 (pH8.2) 1 NP40 台盼兰、 1 mol/L盐酸等。 1.4 Main instruments and reagents: 5mm diameter puncher, microscope, micro blood coagulation test plate, centrifuge, microplate reader, 96-well culture plate, 5% CO 2 incubator, 200 mesh sieve, ink for injection, bean Protein A (ConA), MTT, DNFB, Acetone, Sesame Oil, Depilatory Agent, SPBS, Saline, Chicken Red Blood Cell, Methanol, Giemsa Dyeing Solution, YAC-1 Cell, Hanks Liquid (pH 7.2~7.4), RPMI 1640 Complete Culture Liquid, lithium lactate, iodine nitrotetrazolium chloride (INT), phenazine dimethyl sulfate (PMS), NAD, Tris-HCI buffer (pH 8.2) 1 NP40 trypan blue, 1 mol/L Hydrochloric acid, etc.
1.5实验方法 1.5 experimental methods
1.5.1碳廓清实验和脏器 /体重比值测定: 实验末期, 小鼠稳重后, 按体重从小鼠尾静脉注入稀释的 印度墨汁(lOOmL/kg), 注入墨汁后 2、 lOmin, 分别从内眦静脉丛取血 20uL, 并立即将其加到 2mL 0.1% NaCO3溶液中。用 721分光光度计在 600nm处测光密度值(0D), 以 NaC03溶液做空白对照。 将小鼠处死, 解剖动物, 取出肝脏、 脾脏及胸腺, 用滤纸吸干血迹后稳重。 1.5.1 Carbon clearance test and organ/body weight ratio determination: At the end of the experiment, after the mouse is stabilized, the diluted body is injected from the tail vein of the mouse according to the body weight. Indian ink (100 mL/kg), 2, lOmin after injecting the ink, took 20 uL of blood from the internal iliac venous plexus, and immediately added it to 2 mL of 0.1% NaCO 3 solution. The optical density value (0D) was measured at 600 nm using a 721 spectrophotometer, and the NaCO 3 solution was used as a blank control. The mice were sacrificed, the animals were dissected, the liver, spleen and thymus were removed, and the blood stains were dried with filter paper and then stabilized.
1.5.2迟发型变态反应(DTH): 将试验材料给小鼠连续灌胃 30d后, 每鼠腹部皮肤用脱毛剂进行脱 毛处理, 范围约 3cmX 3cm, 后用 DNFB溶液 50u L均匀涂抹致敏; 5d后, 再用 DNFB溶液 10u L均匀涂抹于小鼠右耳两面, 进行攻击; 24h后, 颈椎脱臼处死小鼠, 剪下左右两耳, 用打孔器取 下直径 5mm的耳片称重。  1.5.2 delayed type hypersensitivity (DTH): After the test material was continuously administered to the mice for 30 days, the skin of each mouse was depilated with a depilatory agent, the range was about 3 cm×3 cm, and then sensitized evenly with 50 uL of DNFB solution; After 5 days, the DNFB solution was evenly applied to both sides of the right ear of the mouse to attack. After 24 hours, the mice were sacrificed by cervical dislocation, and the left and right ears were cut out, and the ear piece with a diameter of 5 mm was removed by a puncher.
1.5.3半数溶血值 (HC5Q ) 的测定和抗体生成细胞检测 (Jeme改良玻片法): 将试验材料给小鼠 连续灌胃 30d后,每只腹腔注射 2 % (体积分数) SRBC的细胞悬液 0.2mL进行免疫。 5d后, 取小 鼠血及脾脏分别做半数溶血值 (HC5Q ) 的测定和抗体生成细胞检测。 1.5.3 Determination of half-hemolytic value (HC 5Q ) and antibody-producing cell assay (Jeme modified slide method): After the test material was administered to mice for 30 days, each intraperitoneal injection of 2% (volume fraction) of SRBC cells 0.2 mL of the suspension was used for immunization. After 5 days, half of the hemolysis value (HC 5Q ) and antibody-producing cells were detected in the blood and spleen of the mice.
1.5.3.1半数溶血值 (HC5Q ) 的测定: 将小鼠摘除眼球取血于离心管中, 放置约 lh,使血清析出, 2000r / min离心 lO min,收集血清。 用生理盐水稀释血清 (300倍), 将稀释后的血清 lmL置试管 内, 依次加入 10% (体积分数) SRBC 0.5mL,补体 lmL (用生理盐水按 1 : 10稀释), 另设不加血 清的对照管 (以生理盐水代替), 置 37°C恒温水浴中保温 15〜30min后, 冰浴终止反应。 2000r / min离心 10 min,取上清液 lmL,加都氏试剂 3mL于试管内, 同时取 10% (体积分数) SRBC 0.25ml 加都氏试剂至 4mL,于另一支试管内, 充分混匀, 放置 lOmin后, 于 540nm处以对照管作空白, 分 别测定各管光密度值。 1.5.3.1 Determination of half hemolysis value (HC 5Q ): The mice were removed from the eyeball and blood was taken from the centrifuge tube, placed for about 1 h, the serum was precipitated, centrifuged at 2000 r / min for 10 min, and serum was collected. The serum was diluted with physiological saline (300 times), and the diluted serum 1 mL was placed in a test tube, and 10% (volume fraction) SRBC 0.5 mL, 1 mL of complement (diluted 1:10 with physiological saline) was added in sequence, and no serum was added. The control tube (replaced with physiological saline) was incubated in a constant temperature water bath at 37 ° C for 15 to 30 minutes, and then the reaction was terminated by an ice bath. Centrifuge at 2000r / min for 10 min, take 1 mL of the supernatant, add 3 mL of Dud reagent to the test tube, and take 10% (volume fraction) SRBC 0.25 ml Addition of Dud reagent to 4 mL. Mix in another tube and mix thoroughly. After lOmin was placed, the control tube was blanked at 540 nm, and the optical density values of the respective tubes were measured.
1.5.3.2抗体生成细胞检测 (Jeme改良玻片法): 取 SRBC免疫 5d后的小鼠脾脏, 放在盛有 Hanks 液的小平皿内, 轻轻磨碎脾脏, 经 200目筛网过滤, 制成单细胞悬液。 离心 10min(1000r/min), 用 Hanks液洗两次,将细胞悬浮于 5mL RPMI 1640培养液中,计数细胞, 并将细胞浓度调整为 5 X 106 个 / mL。将表层培养基加热溶解后, 与等量 P H 7.2〜7.4、 2倍浓度的 H anks液混合, 分装小试管, 每管 0.5mL,再向管内加 50uL10% SRBC, 20UL脾细胞县液, 迅速混匀, 倾倒于已刷琼脂糖薄层的 玻片上, 做平行片, 等琼脂凝固后, 将玻片扣放在片架上, 放入 C02培养箱中孵育 l〜1.5h后, 计 数溶血空斑数。 1.5.3.2 Antibody-producing cell assay (Jeme modified slide method): Take the spleen of mice after 5 days of SRBC immunization, place in a small dish containing Hanks liquid, gently grind the spleen, and filter through a 200 mesh screen. Into a single cell suspension. After centrifugation for 10 min (1000 r/min), the cells were washed twice with Hanks, and the cells were suspended in 5 mL of RPMI 1640 medium, the cells were counted, and the cell concentration was adjusted to 5×10 6 /mL. After heating and dissolving the surface medium, mix it with an equal amount of pH 7.2~7.4, 2 times concentration of Hanks solution, dispense small tubes, 0.5 mL per tube, and then add 50 uL of 10% SRBC, 20UL spleen cell solution to the tube, quickly Mix well, pour on the slide of the thin layer of agarose, make a parallel piece. After the agar solidifies, place the slide on the rack, incubate in the C0 2 incubator for l~1.5h, count the hemolysis Number of plaques.
1.5.4小鼠腹腔巨噬细胞吞噬鸡红细胞实验(半体内法): 将试验材料给小鼠连续灌胃 30d后, 每鼠 腹腔注射 2%鸡红细胞悬液 lmL。 30min后, 颈椎脱臼处死动物, 仰位固定于蜡板上, 正中剪开腹 壁皮肤, 经腹腔注入生理盐水 2mL,转动鼠板 lmin,然后吸出腹腔洗液 lmL,平均分滴于 2片载玻片 上, 放入垫有湿纱布的搪瓷盒内, 于 37°C孵箱温育 30min.孵毕, 在生理盐水中漂洗, 除去未贴片 细胞.晾干, 以 1 : 1丙酮甲溶液固定 20min,4 % (体积分数) Giemsa-磷酸缓冲液染色 3min,再用蒸 馏水漂洗凉干, 于显微镜下计数巨噬细胞. 1.5.4 Mouse peritoneal macrophage phagocytosis chicken red blood cell experiment (half-in vivo method): After the test material was continuously administered to mice for 30 days, each mouse was intraperitoneally injected with 2% chicken red blood cell suspension lmL. After 30 minutes, the animal was sacrificed by cervical dislocation. The animal was fixed on the wax plate in the supine position. The skin of the abdominal wall was cut in the middle. 2 mL of normal saline was injected into the abdominal cavity, and the mouse plate was rotated for 1 min. Then, 1 mL of the peritoneal washing solution was aspirated, and the average was divided into 2 slides. Place in an enamel box with wet gauze and incubate at 37 °C for 30 min. Incubate, rinse in physiological saline, remove unpatched cells, dry, and fix with 1:1 acetone solution for 20 min. 4% (volume fraction) stained with Giemsa-phosphate buffer for 3 min, then steamed The distilled water is rinsed and dried, and the macrophages are counted under a microscope.
1.5.5ConA诱导的小鼠脾淋巴细胞转化实验和小鼠 NK细胞活性测定 (乳酸脱氢酶 LDH测定法): 将试验材料给小鼠连续灌胃 30d后, 颈椎脱臼处死, 无菌取脾, 置于盛有适量无菌 Hanks液的小 平皿中, 用镊子轻轻将脾撕碎, 经 200目筛网过滤, 制成单细胞悬液, 将细胞悬液分为两部分, 分 别于 ConA诱导的小鼠脾淋巴细胞转化实验和小鼠 NK细胞活性测定。  1.5.5ConA-induced spleen lymphocyte transformation test and mouse NK cell activity assay (lactate dehydrogenase LDH assay): After the test material was given to the mice for 30 days, the cervical vertebrae were dislocated and the spleen was aseptically taken. Place in a small plate filled with appropriate amount of sterile Hanks solution, gently smash the spleen with tweezers, filter through a 200 mesh sieve, and make a single cell suspension. The cell suspension is divided into two parts and induced in ConA. Mouse spleen lymphocyte transformation assay and mouse NK cell activity assay.
1.5.5.1ConA诱导的小鼠脾淋巴细胞转化实验: 用 Hanks液洗涤细胞悬液 2次, 每次离心 1.5.5.1 ConA-induced mouse spleen lymphocyte transformation experiment: Wash the cell suspension with Hanks solution twice, each time centrifugation
10min(1000r/min), 然后将细胞悬浮于 lmL的完全培养液中, 台盼兰染色计数活细胞数(在 95%以 上), 调整细胞浓度为 3 X 106个 /mL。 将每份细胞悬液分两孔加入 24孔培养板中, 每孔 lmL,一孔 加 75uLConA液, 另一孔作为对照, 置培养箱中培养 72h。 培养结束前 4h,每孔吸去上清液 0.7mL, 加入 0.7mL不含血清的 RPMI 1640培养液, 同时加入 MTT 50uL/孔, 继续培养 4h。 培养结束后, 每孔加入 lmL酸性异丙醇, 吹打混匀, 使紫色结晶完全溶解。 然后分装到 96孔培养板, 每孔做 3 个平行孔, 用酶标仪以 570nm波长测定光密度值。 After 10 min (1000 r/min), the cells were suspended in 1 mL of complete medium, and the number of viable cells (over 95%) was counted by trypan blue staining, and the cell concentration was adjusted to 3×10 6 cells/mL. Each cell suspension was added to a 24-well culture plate in two wells, 1 mL per well, one well was added with 75 uL of ConA solution, and the other well was used as a control, and cultured in an incubator for 72 hours. 4 h before the end of the culture, 0.7 mL of the supernatant was aspirated per well, and 0.7 mL of serum-free RPMI 1640 medium was added thereto, and MTT 50 uL/well was added thereto, and the culture was continued for 4 hours. After the completion of the culture, 1 mL of acidic isopropanol was added to each well, and the mixture was blown and mixed to completely dissolve the purple crystals. Then, they were dispensed into a 96-well culture plate, and three parallel holes were made per well, and the optical density value was measured by a microplate reader at a wavelength of 570 nm.
1.5.5.2小鼠 N K细胞活性测定 (乳酸脱氢酶 LDH测定法): 试验前 24h将靶细胞传代培养, 应用 前以 Hanks液洗 3次,用 RPMI 1640完全培养液调整细胞浓度为 4 X 105个 / mL。用 Hanks液洗脾 细胞悬液 2次, 每次离心 10min(1000r/min)。 弃上清液后, 加入 0.5mL灭菌水 20s , 裂解红细胞 后再加入 0.5mL2倍 Hanks液及 8mLHanks液,离心 10min(1000r/min),用 lmL完全培养基重悬,用 1%冰醋酸稀释后计数, 台盼兰染色计数活细胞数 (应在 95%以上), 调整细胞浓度为 2 X 107 个 / mL。 取靶细胞和效应细胞各 lOOuL (效靶比 50: 1 ), 加入 96孔培养板中; 靶细胞自然释放孔加靶 细胞和 1%N P 40各 100uL, 上述各项均设三个复孔, 于 37°C、 5%C02培养箱中培养 4h,然后将培 养板离心 ( 1500r/min)5min,每孔吸取上清液 lOOuL置 96孔养板中, 同时加入 LDH基质液 100uL, 反应 3min,每孔加入 lmol/L 的 HCI 30uL, 在酶标仪 490nm处测定光密度值。 实验数据统计: 实验 所得数据采用 SAS软件进行分析。 1.5.5.2 Determination of mouse NK cell activity (Lactate dehydrogenase LDH assay): The target cells were subcultured 24 h before the test, washed three times with Hanks before application, and adjusted to a cell concentration of 4 X 10 with RPMI 1640 complete medium. 5 / mL. The spleen cell suspension was washed twice with Hanks solution and centrifuged for 10 min (1000 r/min) each time. After discarding the supernatant, add 0.5 mL of sterilized water for 20 s, lyse the red blood cells, then add 0.5 mL of 2 times Hanks' solution and 8 mL of Hanks' solution, centrifuge for 10 min (1000 r/min), resuspend with 1 mL of complete medium, and dilute with 1% glacial acetic acid. After counting, trypan blue staining counts the number of viable cells (should be above 95%) and adjusts the cell concentration to 2 X 10 7 cells/mL. Take 100uL of target cells and effector cells (effective target ratio 50: 1), and add to 96-well culture plates; target cells naturally release wells plus target cells and 1% NP 40 each 100uL, each of which has three replicate wells. Incubate in a 37 ° C, 5% CO 2 incubator for 4 h, then centrifuge the plate (1500 r / min) for 5 min, take the supernatant lOOuL per well into a 96-well culture plate, add LDH substrate solution 100uL, reaction for 3min 1 mol/L of HCI 30 uL was added to each well, and the optical density value was measured at 490 nm. Experimental data statistics: The experimental data were analyzed using SAS software.
2.结果 2. Results
2.1本发明保健产对小鼠体重的影响, 结果见表 5至表 9 表 5 碳廓清实验和脏器 /体重实验前后动物体重记录 (¥ ± S)  2.1 The effect of the health care product of the present invention on the body weight of mice, the results are shown in Table 5 to Table 9. Table 5 Animal weight record before and after the organ clearance/body weight test (¥ ± S)
组别与剂量 动物数 1只 体重 / g 增重 / g /[g(kg ·体重)] 试验前 试验后  Group and dose Number of animals 1 body weight / g weight gain / g / [g (kg · body weight)] before the test
对照组 10 18.4士 1.3 22.3 + 1.2 3.9 ± 0.8 Control group 10 18.4 ± 1.3 22.3 + 1.2 3.9 ± 0.8
0.33 10 18.5士 1.4 21.8士 1.3 3.3 ± 0.60.33 10 18.5 士 1.4 21.8 士 1.3 3.3 ± 0.6
0.67 10 18.6士 1.3 22.1 + 1.5 3.5 ± 0.8 1.00 10 18.3± 1.4 21.9士 1.4 3.6 ±0.5 0.67 10 18.6 ± 1.3 22.1 + 1.5 3.5 ± 0.8 1.00 10 18.3 ± 1.4 21.9 ± 1.4 3.6 ± 0.5
表 6 D TH实验前后动物体重记录 (¥ ±S)  Table 6 Animal weight records before and after D TH experiment (¥ ±S)
组别与剂量 动物数 1只 体重 /g 增重 /g  Group and dose Number of animals 1 body weight / g weight gain / g
/[g(kg ·体重)] 试验前 试验后  /[g(kg ·weight)] before the test
对照组 10 18.5 ± 1.4 22.3+ 1.5 3.8士 1.0  Control group 10 18.5 ± 1.4 22.3+ 1.5 3.8 士 1.0
0.33 10 18.4士 1.2 21.8士 1.3 3.4±0.8  0.33 10 18.4士 1.2 21.8士 1.3 3.4±0.8
0.67 10 18.5士 1.3 22.1+ 1.6 3.6+ 1.0  0.67 10 18.5 士 1.3 22.1+ 1.6 3.6+ 1.0
1.00 10 18.6士 1.4 21.8士 1.5 3.2 ±0.9  1.00 10 18.6 士 1.4 21.8 士 1.5 3.2 ±0.9
表 7 半数溶血值 (HC5。)实验和抗体生成细胞实验前后动物体重记录 (X 士 S) Table 7 Half-hemolytic value (HC 5 ). Animal and body weight cell records before and after antibody-producing cell experiments (X S)
Figure imgf000017_0001
经方差分析,三个剂量组与对照组之间各试验前、后,体重以及增重均无显著性差异, P>0.05。 2.2本发明产品对小鼠脏器 I体重比的影响, 结果见表 10。 表 10本发明产品对小鼠脏器 /体重比的影响 (X士 S)
Figure imgf000017_0001
After analysis of variance, there was no significant difference between the three dose groups and the control group before and after each test, body weight and weight gain, P>0.05. 2.2 The effect of the product of the invention on the body weight ratio of the mouse organ I, the results are shown in Table 10. Table 10 Effect of the product of the present invention on the organ/body weight ratio of mice (X Shi S)
Figure imgf000018_0001
注: *表明与对照组比较, P<0.05
Figure imgf000018_0001
Note: * indicates that compared with the control group, P < 0.05
脾脏 /体重比值经方差分析, F = 0.40,P〉0.05。 胸腺 /体重比值经方差分析, F = 3.20,P< 0.05。 Q检验, 人体推荐量的 30倍剂量组与对照组比较, 有显著性差异, P<0.05。  The spleen/body weight ratio was analyzed by variance, F = 0.40, P > 0.05. The thymus/body weight ratio was analyzed by analysis of variance, F = 3.20, P < 0.05. Q test, the 30-fold dose group recommended by the human body was significantly different from the control group, P < 0.05.
2.3本发明产品对小鼠细胞免疫功能 [小鼠脾淋巴细胞转化实验以及小鼠迟发型变态反应 (DTH)] 的影响, 见表 11。 表 11 本发明产品对小鼠细胞免疫功能的影响 (X士 S)
Figure imgf000018_0002
2.3 The effect of the product of the present invention on mouse cellular immune function [mouse spleen lymphocyte transformation experiment and mouse delayed type hypersensitivity (DTH)] is shown in Table 11. Table 11 Effect of the product of the present invention on cellular immune function of mice (X Shi S)
Figure imgf000018_0002
注: *表明与对照组比较 P<0.05 Note: * indicates comparison with the control group P<0.05
淋巴细胞增殖试验的 0D差值经方差分析, F = 2.86,P<0.05。 Q检验, 人体推荐量的三个剂量 组与对照组比较, P<0.05, 有显著性差异。 耳肿程度经方差分析, F = 3.42,P<0.05。 Q检验, 人 体推荐量的 30倍剂量组与对照组比较, P<0.05, 有显著性差异。  The 0D difference of the lymphocyte proliferation test was analyzed by analysis of variance, F = 2.86, P < 0.05. In the Q test, the three dose groups recommended by the human body were compared with the control group, P < 0.05, and there was a significant difference. The degree of ear swelling was analyzed by analysis of variance, F = 3.42, P < 0.05. According to the Q test, the 30-fold dose group of the human body recommended was compared with the control group, P < 0.05, and there was a significant difference.
2.4本发明产品对小鼠体液免疫功能(抗体生成细胞测定以及小鼠半数溶血值测定) 的影响, 见表 12。 表 12本发明产品对小鼠体液免疫功能的影响 ( ¥ ± S) 组别与剂量 抗体生成细胞检测 (溶血空斑数 / 半数溶血值 (HC50) 2.4 The effect of the product of the present invention on humoral immune function (measurement of antibody-producing cells and determination of half-hemolytic value in mice) of mice is shown in Table 12. Table 12 Effect of the product of the present invention on humoral immune function of mice (¥ ± S) Group and dose antibody-producing cell assays (number of hemolytic plaques / half hemolysis value (HC 50 )
/[g(kg ·体重)] 动物数 1只 106脾细胞) /[g(kg·weight)] number of animals 1 only 10 6 spleen cells)
对照组 10 264士 60 155.08 ±9.88  Control group 10 264 士 60 155.08 ±9.88
0.33 10 356 ±66* 159.02 ±7.83 0.33 10 356 ±66* 159.02 ±7.83
0.67 10 343 ±78* 156.59 ±8.08 0.67 10 343 ±78* 156.59 ±8.08
1.00 10 348 ±54* 169.56士 11.23** 注: *表明与对照组比较 P<0.05, **表明与对照组相比较, P<0.01 1.00 10 348 ±54* 169.56士 11.23** Note: * indicates P<0.05 compared with the control group, ** indicates that compared with the control group, P<0.01
溶血空斑数经方差分析, F=4.33,P<0.05。 Q检验, 三个剂量组与对照组相比较, 有显著性 差异, P<0.05; HC5。经方差分析, F=4.88,P<0.01。 Q检验, 30倍剂量组与对照组相比较, 有极 显著性差异, P<0.01。 The number of hemolytic plaques was analyzed by variance, F=4.33, P<0.05. Q test, the three dose groups compared with the control group, there was a significant difference, P <0.05; HC 5 . After analysis of variance, F = 4.88, P < 0.01. Q test, 30 times the dose group compared with the control group, there was a significant difference, P <0.01.
2.5本发明产品对小鼠腹腔巨噬细胞吞噬鸡红细胞能力的影响, 见表 13。 表 13本发明产品对小鼠腹腔巨噬细胞吞噬鸡红细胞能力的影响 (X 士 S) 组别与剂量 小鼠腹腔巨噬细胞吞噬鸡红细胞能力  2.5 The effect of the product of the invention on the ability of mouse peritoneal macrophages to phagocytose chicken red blood cells, see Table 13. Table 13 Effect of the product of the present invention on the ability of mouse peritoneal macrophages to phagocytose chicken red blood cells (X Shi S) Group and dose The ability of mouse peritoneal macrophages to engulf chicken red blood cells
/[g(kg ·体重 动物数 1只  /[g(kg ·weight animal number 1
吞噬率 1 % 吞噬指数  Phagocytosis rate 1 % phagocytic index
对照组 10 23.1 ±4.8 0.35 ±0.05  Control group 10 23.1 ±4.8 0.35 ±0.05
0.33 10 28.6±6.1 0.40 ±0.05  0.33 10 28.6±6.1 0.40 ±0.05
0.67 10 27.8 ±5.6 0.40 ±0.05  0.67 10 27.8 ±5.6 0.40 ±0.05
1.00 10 26.4 ±5.6 0.44 ±0.06*  1.00 10 26.4 ±5.6 0.44 ±0.06*
注: *表明与对照组比较, P<0.05 Note: * indicates that compared with the control group, P < 0.05
小鼠腹腔巨噬细胞吞噬鸡红细胞的吞噬率经方差分析, F=1.94,P〉0.05。 吞噬指数经方差分 析, F = 3.16,P<0.05o Q检验, 30倍剂量组与对照组相比较, Ρ<0· 05, 有显著性差异。  The phagocytosis rate of mouse peritoneal macrophages phagocytized chicken red blood cells was analyzed by variance, F=1.94, P>0.05. The phagocytic index was analyzed by square differential analysis, F = 3.16, P < 0.05 o Q test, and the 30-fold dose group compared with the control group, Ρ < 0.05, there was a significant difference.
2.6本发明产品对小鼠 ΝΚ细胞活性的影响, 见表 14。 表 14本发明产品对小鼠 Ν Κ细胞活性的影响 ( X 士 S) 2.6 The effect of the product of the invention on the activity of mouse sputum cells is shown in Table 14. Table 14 Effect of the product of the present invention on the activity of mouse sputum cells (X S)
Figure imgf000019_0001
Figure imgf000019_0001
注: *表明与对照组比较, P<0.05 Note: * indicates that compared with the control group, P < 0.05
经方差分析, F = 4.14. P<0.05。 Q检验, 30倍剂量组与对照组相比较, P<0.05, 有显著差异。 3.结论 ( 1 ) 本发明产品三个剂量组均未见对动物体重及体重增长有明显的影响。 After analysis of variance, F = 4.14. P < 0.05. Q test, 30 times the dose group compared with the control group, P <0.05, there was a significant difference. 3. Conclusion (1) The three dose groups of the present invention did not have a significant effect on animal body weight and body weight growth.
( 2 ) 本发明产品人体推荐量的 30倍剂量组的胸腺 /体重比值与对照组比较, 有显著性差异。 (2) The thymus/body weight ratio of the 30-fold dose group recommended by the human body of the present invention was significantly different from that of the control group.
( 3 ) 小鼠细胞免疫功能试验表明, 在脾淋巴细胞转化实现中, 本发明产品人体推荐量的三个剂量 组 0D差值显著高于对照组, 呈阳性结果; 迟发型变态反应实验表明, 耳肿程度与对照组比较, 30 倍剂量组差异显著, 呈阳性结果。 (3) The mouse cell immune function test showed that in the realization of spleen lymphocyte transformation, the 0D difference of the three dose groups recommended by the human body of the present invention was significantly higher than that of the control group, and the positive result was obtained; the delayed type allergic reaction experiment showed that Compared with the control group, the degree of ear swelling was significantly different between the 30-fold dose group and a positive result.
( 4) 小鼠体液免疫功能实验表明, 在抗体生成细胞实验中, 与对照组相比, 本发明产品三个剂量 组脾细胞溶血空斑数显著升高, 呈阳性结果; 小鼠半数溶血值测定表明, 30倍剂量组的 HC5。值与 对照组比较有极显著差异, 呈阳性结果。 (4) The humoral immune function test of mice showed that in the antibody-producing cell experiment, compared with the control group, the number of hemolytic plaques in the spleen cells of the three dose groups of the present invention was significantly increased, and the positive result was obtained; assay showed that, HC 5 30 times dose group. The value was significantly different from the control group and showed a positive result.
( 5 )小鼠单核一巨噬细胞功能实验结果表明, 在小鼠碳廓清实验中, 本发明产品 30倍剂量组的吞 噬指数显著高于对照组, 呈阳性结果; 小鼠巨噬细胞吞噬鸡红细胞试验表明, 30倍剂量组的吞噬 指数显著高于对照组, 呈阳性结果  (5) The results of mouse monocyte-macrophage function test showed that the phagocytic index of the 30-fold dose group of the present invention was significantly higher than that of the control group in the mouse carbon clearance test; the mouse macrophage phagocytosis Chicken red blood cell test showed that the phagocytic index of the 30-fold dose group was significantly higher than that of the control group, showing a positive result.
( 6 ) NK细胞活性测定实验表明,与对照组比较,本发明产品 30倍剂量组 NK细胞的活性显著升高, 呈阳性结果。  (6) The NK cell activity assay showed that the activity of NK cells in the 30-fold dose group of the present invention was significantly higher than that of the control group, and a positive result was obtained.
依据卫生部 《保健食品检验与评价技术规范》 (2003 ) 年版判定标准, 由以上结果判定本发明 产品具有明显的增强免疫力的功能。 实验例 5 : 试验统计表明: 用本发明的保健食品实施例 2对 20名糖尿病患者作治疗试验, 取得显著疗效 的占 52%, 基本有效的占 43%, 无效的占 4%, 总有效率达 96%, 且均表示服用本发明的保健食品后, 精神状态非常好, 且免疫力有较大的提高。  According to the judgment standard of the "Technical Specification for Health Food Inspection and Evaluation" (2003) of the Ministry of Health, it is judged from the above results that the product of the present invention has an obvious function of enhancing immunity. Experimental Example 5: Test statistics showed that: 20 patients with diabetes were treated with the health food example 2 of the present invention, 52% obtained remarkable effects, 43% was basically effective, 4% was ineffective, and total efficiency was 4%. Up to 96%, and both indicate that after taking the health food of the present invention, the mental state is very good, and the immunity is greatly improved.
基本治愈标准: 三多自觉症状消失, 化验空腹血糖正常, 尿糖阴性。  The basic cure criteria: more than three symptoms disappeared, the test fasting blood glucose is normal, urine sugar is negative.
显效: (具有下列三项中的二项者) (1 )三多症状基本消失; (2) 空腹血糖基本正常; (3 ) 24小时尿糖定量阴性或 <5克, 尿糖定性阴性。  Significant effect: (with two of the following three items) (1) The symptoms of the three symptoms basically disappeared; (2) The fasting blood glucose is basically normal; (3) The 24-hour urine sugar is negative or <5 g, and the urine sugar is negative.
有效: (具有下列三项中的二项者) (1 ) 空腹血糖下降 20%以上; (2) 三多症状明显好转; (3 ) 尿糖定量减少 50%以上。  Effective: (with two of the following three items) (1) Fasting blood glucose decreased by more than 20%; (2) Three symptoms were significantly improved; (3) Urine sugar was reduced by more than 50%.
无效: 临床三多症状无好转, 血糖下降不明显 典型病例一: 隋 XX, 男, 50岁, 患糖尿病 6年。 空腹血糖 18. 6 , 经常胸闷、 失眠、 两脚发 麻、 两唇发干但不爱喝水, 小便不频, 打胰岛素〈 长效 〉 中午 30 单位, 晚上 28 单位, 血糖始 终达不到正常, 后来经过朋友介绍知道本保健食品的效果, 刚开始抱着试试的心理服用一个月, 胰 岛素中午减到 10 单位, 晚上停用胰岛素, 血糖平稳降到了正常, 经过三个疗程治疗后, 上述症状 消失。 Invalid: Clinical symptoms are not improved, blood glucose is not obvious. Typical case 1: 隋XX, male, 50 years old, suffering from diabetes for 6 years. Fasting blood sugar 18.6, often chest tightness, insomnia, numbness in both feet, dry lips but do not like to drink water, urinating is not frequent, playing insulin <long-term effect> 30 units at noon, 28 units at night, blood sugar is not up to normal Later, after a friend introduced the effect of the health food, I just started taking the psychological test for a month, pancreas The island was reduced to 10 units at noon, and insulin was stopped at night. The blood sugar level dropped to normal. After three courses of treatment, the above symptoms disappeared.
典型病例二: 丁 XX, 女, 48岁, 患糖尿病 5 年, 当时查空腹血糖 12. 8mmol/L, 餐后二小时 血糖 19. 5mmol/L 尿糖 (+ + +), 体重由 130 斤减到 100 斤, 感到没劲、 烦渴、 多饮、 多尿、 多 食症状明显, 且视物模糊, 后服二甲双胍、 美比达、 糖适平等降糖药, 血糖控制基本正常, 因担心 西药对肝肾有损害, 一直有心理负担, 希望能服中药治疗。 09年 11月到北京串门, 经过朋友介 绍知道本保健食品的效果, 开始服用, 两盒后感到两眼看东西不再模糊了, 测血糖 5. 9mmol/L, 在服第二个疗程时, 血糖一直保持在正常范围, 精神放松了, 能参加各种活动和正常人一样, 很开 心, 体重由 100 斤增加到 110 斤, 最近复查糖化血红蛋白由原来的 10. 56% 降到 6. 75% , 血压 逐渐恢复正常, 人的精神状态也有了很大的改善。  Typical case 2: Ding XX, female, 48 years old, suffering from diabetes for 5 years, then check the fasting blood glucose 12. 8mmol / L, two hours after the meal, blood glucose 19. 5mmol / L urine sugar (+ + +), weight loss from 130 kg To 100 kilograms, feeling boring, polydipsia, polydipsia, polyuria, polyphagia, and blurred vision, after taking metformin, mebida, sugar and equal hypoglycemic agents, blood sugar control is basically normal, because of fear of Western medicine Liver and kidney are damaged, there is always a psychological burden, I hope to take Chinese medicine treatment. In November 2009, I went to Beijing to go to the door. After a friend introduced the effect of the health food, I started taking it. After two boxes, I felt that my eyes were no longer blurred. I measured blood sugar 5. 9mmol/L. When I took the second course of treatment, blood sugar. Always staying in the normal range, the spirit is relaxed, can participate in various activities and the same as normal people, very happy, the weight increased from 100 kg to 110 kg, the recent review of glycated hemoglobin from the original 10.56% to 6. 75%, The blood pressure gradually returned to normal, and the mental state of the person also improved greatly.

Claims

权利要求书 Claim
1、 一种增强机体免疫力并能控制糖尿病的产品, 由有效成分和辅料组成, 所述有效成分由如下组分组成: 北虫草提取物 5-10份, 千佛菌提取物 35-50份, 香菇多糖 20-30份,葛根异黄酮 5-10份,枸杞提取物 7-15份、鸡腿菇提取物 8-20 份; 其中, 北虫草提取物, 千佛菌提取物, 枸杞提取物和鸡腿菇提取物是以水作 为溶剂提取, 采用中药常规水提方法提取得到的。  1. A product for enhancing immunity and controlling diabetes, comprising an active ingredient and an auxiliary material, the active ingredient consisting of the following components: 5-10 parts of Cordyceps militaris extract, 35-50 parts of Thousand Buddha extract 20-30 parts of lentinan, 5-10 parts of puerarin isoflavone, 7-15 parts of medlar extract, 8-20 parts of Coprinus comatus extract; wherein, Cordyceps militaris extract, Thousand Buddha extract, alfalfa extract and The extract of Coprinus comatus is extracted with water as a solvent and extracted by a conventional water extraction method of traditional Chinese medicine.
2、 根据权利要求 1所述的增强机体免疫力并能控制糖尿病的产品, 所述有 效成分由如下组分组成: 北虫草提取物 5-8份, 千佛菌提取物 40-45份, 香菇多 糖 25-30份, 葛根异黄酮 6-8份, 枸杞提取物 10-15份、 鸡腿菇提取物 10-18份。  2. The product for enhancing immunity and controlling diabetes according to claim 1, wherein the active ingredient is composed of the following components: 5-8 parts of Cordyceps militaris extract, 40-45 parts of Thousand Buddha extract, shiitake mushroom 25-30 parts of polysaccharide, 6-8 parts of puerarin isoflavone, 10-15 parts of medlar extract, and 10-18 parts of hamweed mushroom extract.
3、 根据权利要求 2所述的增强机体免疫力并能控制糖尿病的产品, 所述有 效成分由如下组分组成: 北虫草提取物 6份, 千佛菌提取物 40份, 香菇多糖 25 份, 葛根异黄酮 7份, 枸杞提取物 10份、 鸡腿菇提取物 12份。  3. The product for enhancing immunity and controlling diabetes according to claim 2, wherein the active ingredient is composed of the following components: 6 parts of Cordyceps militaris extract, 40 parts of Thousand Buddha extract, 25 parts of lentinan, 7 parts of Pueraria lobata, 10 parts of Lycium barbarum extract, and 12 parts of Coprinus comatus extract.
4、 根据权利要求 1所述的增强机体免疫力并能控制糖尿病的产品, 所述辅 料中含有甜味剂。  A product for enhancing immunity of a living body and for controlling diabetes according to claim 1, wherein said auxiliary material contains a sweetener.
5、 根据权利要求 4所述的增强机体免疫力并能控制糖尿病的产品, 所述甜 味剂为甜菊糖甙, 重量份为 0.2-0.5份。  The product for enhancing immunity of a living body and for controlling diabetes according to claim 4, wherein the sweetener is stevioside in an amount of 0.2 to 0.5 parts by weight.
6、 根据权利要求 1所述的增强机体免疫力并能控制糖尿病的产品, 所述产 品的剂型为片剂、 胶囊剂、 颗粒剂、 口服液, 或者饮料、 袋泡茶。  6. A product for enhancing immunity and controlling diabetes according to claim 1, wherein the product is in the form of a tablet, a capsule, a granule, an oral solution, or a beverage or a teabag.
PCT/CN2011/079493 2010-09-16 2011-09-09 Product of functional health food that enhances organ immunity WO2012034498A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010285489.3 2010-09-16
CN2010102854893A CN101999575B (en) 2010-09-16 2010-09-16 Product for enhancing organism immunity and controlling diabetes

Publications (1)

Publication Number Publication Date
WO2012034498A1 true WO2012034498A1 (en) 2012-03-22

Family

ID=43807463

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2011/079493 WO2012034498A1 (en) 2010-09-16 2011-09-09 Product of functional health food that enhances organ immunity

Country Status (2)

Country Link
CN (1) CN101999575B (en)
WO (1) WO2012034498A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103750321A (en) * 2014-01-24 2014-04-30 杨子驿 Detoxification and health-care food
CN110250516A (en) * 2019-07-11 2019-09-20 中国科学院烟台海岸带研究所 It is a kind of with relieving stress with the composition of strengthen immunity and preparation method thereof
CN111109587A (en) * 2018-11-01 2020-05-08 韩连慧 Food with effects of reducing blood glucose level in human body and enhancing immunity and preparation method thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101999575B (en) * 2010-09-16 2011-08-17 武斌 Product for enhancing organism immunity and controlling diabetes
CN103893256A (en) * 2012-12-31 2014-07-02 天津天狮生物发展有限公司 Traditional Chinese medicine composition for enhancing immunity and preparation method thereof
CN103239470B (en) * 2013-05-16 2015-01-07 陕西众兴菌业科技有限公司 Dual-mushroom polysaccharide composition containing coprinus comatus polysaccharide and lentinan as well as preparation method and application thereof
CN103750330B (en) * 2014-02-18 2015-02-25 安国同源堂生物科技有限公司 Oral composition comprising bovine bone marrow powder and preparation method of oral composition
CN105250339A (en) * 2015-10-10 2016-01-20 大连春天生物菌业孵化基地有限公司 Composition capable of decreasing blood sugar and preparation method thereof
CN106551229A (en) * 2016-11-15 2017-04-05 上海市农业科学院 A kind of compound edible mushroom solid beverage
CN107019143A (en) * 2017-04-12 2017-08-08 山东菌芝堂生物科技发展有限公司 A kind of instant porridge for recovering diabetes B Intestinal Mucosal Injury in Patients Undergoing colony balance and preparation method thereof
CN107260768B (en) * 2017-06-21 2018-06-22 云南多糖生物科技有限公司 A kind of mushroom complex polysaccharide composition and its preparation method and application
CN107223983A (en) * 2017-07-10 2017-10-03 张志才 The fermentate of the solid state transformed Chinese yam of coprinus comatus and its application
CN109806276A (en) * 2019-04-04 2019-05-28 辽宁大学 Lentinan prevents the application in diabetes complicated disease drug in preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1079027C (en) * 1996-11-01 2002-02-13 参天堂制药株式会社 Pharmaceutical composition for diabetes
CN1279946C (en) * 2004-07-14 2006-10-18 张国强 Medicinal wine and its producing method
CN101999575A (en) * 2010-09-16 2011-04-06 武斌 Product for enhancing organism immunity and controlling diabetes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1055638C (en) * 1995-07-14 2000-08-23 李江 Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method
CN1309984A (en) * 2000-02-24 2001-08-29 王光明 Biological preparation for preventing and treating cardio-and cerebro-vascular disease and diabetes, nursing face and invigorating kidney and its preparation process
CN1611249A (en) * 2003-10-29 2005-05-04 孟昭宇 Antisenescent longevity powder
CN100352379C (en) * 2004-11-10 2007-12-05 李祥麟 Nutritious liquor (drink) for relieving the effect of alcohol, alcohol relieving capsule production method
CN1275543C (en) * 2004-12-31 2006-09-20 北京东方兴企食品工业技术有限公司 Composite fungi amylose nutrient
CN100998403A (en) * 2006-12-22 2007-07-18 苏明寿 Composite nutrition nourishing containing Chinese wolfberry
CN101015571B (en) * 2007-03-13 2010-09-08 陈林生 Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process
CN101204504A (en) * 2007-11-30 2008-06-25 广州中一药业有限公司 Medicament composite for diabetes mellitus and preparation method threreof
CN101248869A (en) * 2008-04-09 2008-08-27 李勇 Method for preparing health care food by edible fungus mycelium or seed
CN101507502B (en) * 2009-03-30 2012-06-06 安徽省农业科学院蚕桑研究所 Bag tea containing Chinese caterpillar fungus and mulberry-leaf and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1079027C (en) * 1996-11-01 2002-02-13 参天堂制药株式会社 Pharmaceutical composition for diabetes
CN1279946C (en) * 2004-07-14 2006-10-18 张国强 Medicinal wine and its producing method
CN101999575A (en) * 2010-09-16 2011-04-06 武斌 Product for enhancing organism immunity and controlling diabetes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NIU, TINGXIAN ET AL.: "Research progress of Chinese medicines on strengthening immune function of organism", JOURNAL OF TRADITIONAL CHINESE VETERINARY MEDICINE, no. 3, 1998, pages 38 - 40 *
PENG, CONG ET AL.: "Research progress of Chinese medicines used commonly for treating diabetes and its complications", HUBEI JOURNAL OF TRADITIONAL CHINESE MEDICINE, vol. 30, no. 1, 2008, pages 60 - 62 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103750321A (en) * 2014-01-24 2014-04-30 杨子驿 Detoxification and health-care food
CN111109587A (en) * 2018-11-01 2020-05-08 韩连慧 Food with effects of reducing blood glucose level in human body and enhancing immunity and preparation method thereof
CN110250516A (en) * 2019-07-11 2019-09-20 中国科学院烟台海岸带研究所 It is a kind of with relieving stress with the composition of strengthen immunity and preparation method thereof

Also Published As

Publication number Publication date
CN101999575B (en) 2011-08-17
CN101999575A (en) 2011-04-06

Similar Documents

Publication Publication Date Title
WO2012034498A1 (en) Product of functional health food that enhances organ immunity
JP6271571B2 (en) Composition for maintaining intestinal microbiota equilibrium, process for producing the composition, and use of the composition
CN104432084B (en) A kind of conditioning powder and its production and use
CN102919836B (en) Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof
KR101144059B1 (en) Composition for prevention or treatment of diabete or obesity comprising Punica granatum extract and red ginseng extract
CN104643250A (en) Solid beverage capable of bidirectionally regulating body weight and improving subhealth
CN101274078A (en) Natural plant extract and preparing method and application of the same
CN107156363A (en) A kind of complex tea with effect of weight reducing and preparation method thereof
CN101766274B (en) Antioxidant functional food composition containing bamboo-leaves flavones
KR20160117034A (en) Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof
CN111771988A (en) Nutritional food suitable for diabetic patients and preparation method thereof
CN104857154A (en) Traditional Chinese medicine composition for treating three-high diseases and preparation method therefor
US20180296615A1 (en) Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient
CN104147345B (en) A kind of Chinese medicine composition for treating cardiovascular autonomic neuropathy
CN1839702A (en) Compound Gynostemma pentaphylla tea for assisting invigorating brain and heart and its preparation method
CN101243883B (en) Health food with function of reducing blood sugar and its preparation
CN108813610A (en) A kind of saussurea involucrata composition and its application for improving immunity
CN102090637A (en) Collagen-containing compound nutritious powder
KR20100129571A (en) Functional composition for improvement of sex and food having the same
CN108771246A (en) It improves the immunity of patient after postoperative or chemotherapy and restores the composition of physiological function
CN101816698B (en) Composition for preventing and curing metabolism disturbance syndrome
KR102192586B1 (en) Phamaceutical composition for treating fatty liver disease and health functional for improving liver function comprising extracts or powder of Pleurotus eryngii var. ferulea (Pf.)
CN113842452A (en) Medicine composition for treating diabetes and preparation method thereof
CN112690449A (en) Cereal conditioning porridge for middle-aged and old people
CN106138900A (en) Auxiliary treats hyperglycemia and the compositions of diabetic complication and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11824568

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11824568

Country of ref document: EP

Kind code of ref document: A1